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ABSTRACT 
The TBJ is a unique anatomical zone which transmits high tensile loads from aligned, fibrous 
tendon to stiff bone. Injuries to the rotator cuff account for 4.5 million physician visits per year 
and an annual 250,000 surgeries in the United States alone. However, current surgical techniques 
do not provide regeneration at the tendon bone junction (TBJ) and the re-failure rate is extremely 
high (>90%). This thesis explores approaches to develop a porous collagen-glycosaminoglycan 
(CG) biomaterial containing overlapping patterns of structural and biomolecular properties to 
promote TBJ regeneration. Notably, we describe a scaffold containing a gradient interfacial zone 
between mineralized and non-mineralized CG scaffold compartments. Fabricated via 
lyophilization, we explore use of diffusion-based approaches to form the gradient interface. We 
also describe an approach to create an interdigitated interface, and showed composite elastic 
modulus and failure load increased with increasing interdigitation. Next, we examined cellular 
response after tensile strain across two multi-compartment scaffold variants, one containing only 
a mineral gradient (layered) and the other incorporating microstructural alignment characteristic 
of the native osteotendinous interface (osteotendinous). We found that layered scaffolds induce 
very little change in nuclear elongation (aspect ratio) or nuclear orientation of human 
mesenchymal stem cells, while the osteotendinous scaffolds induces an increase in nuclear 
aspect ratio and alignment with strain. Most notably, cell nuclei and actin fibers were more 
aligned and aspect ratio was increased at 0% strain in the non-mineralized compartment of the 
osteotendinous scaffold. This suggests that pore architecture alone was responsible for the 
cellular response. Finally, we demonstrated orthogonal approaches to both define the elastic 
modulus and patterned biomolecules (PDGF-BB for proliferation; BMP-2 for osteogenesis) on 
CG membranes. Using this approach to explore how biomolecular and biophysical cues may 
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work synergistically to direct MSC fate, we saw an increase in proliferation with covalently-
bound PDGF-BB, while BMP-2 did not impact proliferation. In the PDGF-BB patterned 
membranes, we saw that osteogenesis was positively correlated with stiffness but inversely 
correlated with proliferation. In the BMP-2 patterned scaffolds, osteogenesis was positively 
correlated stiffness and adipogenesis was inversely correlated with stiffness. These results 
suggest that mechanical and biomolecular cues play an integral role in cellular response. 
Considered together, the approaches described here provide a platform to spatially manipulate 
biomolecular and biophysical cues across a collagen biomaterial in order to elicit cellular 
responses of interest for orthopedic interface repair. Moving forward, these approaches will be 
integrated into a single construct to provide basic cues to enhance TBJ healing and regeneration 
after injury. 
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CHAPTER 1: INTRODUCTION
 
1.1: The Tendon-Bone Junction: Motivation and Injury Model 
The tendon-bone junction (TBJ) is a unique anatomical zone connecting highly aligned, elastic 
tendon to stiff, mineralized bone. The TBJ transmits high tensile loads from the tendon to the 
bone for the primary purpose of movement. Due to 100-fold differences in mechanical properties 
of tendon (0.4 GPa) and bone (20 GPa)1, the TBJ experiences high stress concentrations which it 
must dissipate without failure. It does this through local gradients in extracellular matrix (ECM) 
proteins, growth factors (GF), mineral content, and stiffness (Figure 1.1).1-4  
 
TBJ injuries such as rotator cuff tears are common, with more than 4.5 million physician visits 
and 250,000 surgeries nationally each year.5 In a rotator cuff tear, the tendon typically tears away 
from the bone, the humeral head in this case. To reattach the rotator cuff tendon to the humeral 
head, surgeons typically suture the tendon to holes they have drilled into the bone (Figure 1.2). 
During the healing process, the gradients in ECM proteins, GF, and mineral content are replaced 
by scar tissue, which lacks the functionality of the TBJ. This leads to extremely high (>90%) re-
failure rates in some cases.1 Although this approach is successful for many patients, there is a 
large field of research being conducted to explore different methods and techniques of surgical 
anchoring and reattachment.6-12 These techniques have lower success rates as the patient’s age 
increases, which is concerning as the United States population ages and life expectancies 
increase.13-15 Rotator cuff surgical outcome is also affected by the type and shape of the tear 
being repaired8,16,17 and pre- and post- operative physical treatment.6,12,18-21 
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Another common injury is the anterior cruciate ligament (ACL) tear. Although ACL tears occur 
within the bulk of the ligament tissue, repair of the ACL involves replacing the ligament and 
promoting ligament (instead of tendon) to bone healing. However, many of the same concerns in 
healing a multi-tissue interface are present. Post-operative re-failure rates for the ACL are not as 
high as the TBJ (~8%)22, but surgical approaches are limited in other ways. The most common 
repair method involves removing a piece of the patellar tendon—which attaches the knee cap to 
the tibia—from the patient’s knee, maintaining the native bone-ligament-bone interfaces (Figure 
1.3(B)). Bone tunnels are drilled into the tibia and femur and the bone portions of the patellar 
tendon are attached via screws into the knee. Although this maintains the ligament-bone 
interfaces, this method also creates donor site morbidity23, leaving patients with difficulty 
kneeling, lingering pain, and an increased incidence of osteoarthritis of the knee joint.24-26 This 
method is also limited if the patient tears their ACL multiple times or has a re-failure. An 
alternative to the patellar tendon is a hamstring tendon graft. However, this graft does not 
provide a pre-existing bone-ligament-bone structure. Because of this, the patellar tendon graft is 
the “golden standard” of ACL reconstruction (Figure 1.3).27 
 
In this thesis, we examine two fundamental elements of a successful biomaterial approach to 
provide better healing and regenerative capacity across the TBJ. In both ACL and rotator cuff 
reconstruction, regenerative medicine approaches may offer the ability to engineer cellular 
microenvironments to better restore injured tissues. To achieve this, we must develop biomaterial 
approaches which can utilize stem cells isolated from the patient’s own body. This biomaterial 
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can be designed with distinct compartments for tendon, bone, and insertion regeneration using 
compartment-specific biochemical and biophysical cues to direct stem cell fate. 
 
1.2: Engineering Porous Biomaterial Microenvironments 
Biomaterials must provide a microenvironment which can support and recruit tissue-specific 
cells, while also mimicking the mechanical and biophysical properties of the tissue as a whole. 
While the specifics of these criteria change depending on the tissue application, there are 
fundamental tradeoffs between pore size, permeability, and mechanical properties that are 
integral to any porous biomaterial scaffold. These tradeoffs are expressed as 
∗ =  ∗	
        (Equation 1.1)  
where ∗ is the elastic modulus of the porous construct,   is the elastic modulus of the solid,  
is specific surface area, ∗ is the density of the porous construct, and   is the density of the 
solid.28 All of the mechanical properties discussed within this section stem from this relationship.  
 
1.2.1: Pore size influence on cellular behavior 
Typical synthetic materials have pore sizes which range from the 10 nm to 1 mm,29-34 depending 
on how they are created. In order to be used as a template for cellular growth, pores should be 
large enough to allow for nutrient transport and cellular infiltration (approximately 50 to 400 µm 
depending on cell type), while maintaining appropriate tissue-dependent mechanical integrity. 
Pore size also influences the specific surface area, permeability, and elastic modulus of the 
material, as expressed in Equation 1.1. Often, there is an optimal range of pore sizes for cellular 
applications, typically between 200 and 400 µm, which balances these parameters.35-40 
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Specific surface area, which is the total surface area per unit volume, is inversely related to pore 
size. In general, initial cellular attachment increases with an increase in specific surface area.38 
Although initial cellular attachment influences all future cellular proliferation and activity, an 
increase in specific surface area translates to a decrease in permeability. Permeability, or the rate 
at which liquid can pass through a porous material, increases with pore size. Permeability of 
tissue engineering scaffolds is on the order of 10-9-10-12 m2, and influences how nutrients diffuse 
through the scaffold and reach the cell. Furthermore, an increase in permeability can allow cells 
to withstand higher flow rates without negative consequences. These properties allow an increase 
in cellular proliferation, differentiation, and waste removal.36,38,41 With decreased permeability, 
there is a decrease in nutrient transport and autocrine signaling in addition to limited cell 
recruitment and mobility.35,38,42,43 Pore size must be carefully selected in order to balance the 
tradeoff between specific surface area and permeability. 
 
1.2.2: Pore Shape 
In addition to pore size, pore shape has been shown to influence cellular behavior in porous 
structures. Many tissues have an inherent architecture which can be described generally as a 
shape; these small microenvironmental cues can provide cells with powerful, tissue-specific 
behavioral information. For example, tendons and muscles are highly aligned, anisotropic tissues 
with a high aspect ratio. The anisotropy of native tissues has motivated efforts to develop 
biomaterials containing similar mechanical microenvironment to produce better cellular 
bioactivity. Tenoctyes and cardiomyocytes both display higher degrees of tissue-specific 
bioactivity when cultured in three-dimensional (3D) materials with aligned pore geometry.29,44 In 
mesenchymal stem cells, anisotropic pores have shown to induce differentiation towards a 
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tenogenic lineage more than an isotropic pore structure.29,45,46 Circular pores have been shown to 
steer mesenchymal stem cells towards an adipogenic lineage, while star-like pores have directed 
the same cells to produce osteogenic markers.45-47 Moving forward, it still remains an open 
question as to how to best leverage these observations to create biomaterials for regenerative 
repair of orthopedic insertional tissues. 
 
1.2.3: Mechanical Considerations 
Different tissues throughout the body also have very different stiffness and mechanical properties 
which provide cellular information as well. The elastic modulus of the extracellular matrix 
ranges from approximately 0.1 kPa in the brain to approximately 20 GPa in cortical bone.48 Cells 
can perceive their mechanical environment by generating contractile forces to sense their 
surroundings. The stiffness of the matrix can influence stem cell fate decisions through the 
activation or hindrance of cytoskeletal organization and mechanotransduction pathways. This has 
been shown to drive stem cells down tissue-specific lineages (such as brain and muscle) via 
biomaterial surfaces that provide the corresponding elastic modulus of the tissue.48 
 
Matrix stiffness may also sensitize cells to exogenous biomolecular cues. In the case of 
osteocytes, or bone cells, an increase in stiffness alone can produce osteogenic fate decisions. 
However, when provided with mechanoenvironmental signals in the form of a soft surrounding 
matrix in addition to a bone morphogenic protein (BMP-2), the protein’s produces mixed 
effects.49,50 Zouani et al demonstrated that a stiffer substrate (>3.5 kPa) is required for BMP-2 to 
produce any effect on stem cell fate, but that this effect was not synergistic.49 However, Tan et al 
found a synergetic effect of matrix stiffness and BMP-2 using a hydrogel-based platform. This 
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result may be complicated by the fact that the stiffer hydrogels had a decreased porosity, and 
may provide an increased surface area for both BMP-2 and cells to adhere to. However, both of 
these studies support the conclusion that cells receive information through multiple sources and 
behave in a manner that is only consistent with all presented cues.  
 
Some tissues, such as those found in the musculoskeletal system, are mechanically dynamic. In 
order for these tissues to produce and maintain healthy cellular activity, they must provide the 
correct cellular cues through cyclic loading. For example, there is a balance between osteoblasts 
(bone forming cells) and osteoclasts (bone remodeling cells) in bone.51 Bone formation via 
osteoblasts is triggered by active loading, such as exercise, while bone resorption via osteoclasts 
occurs after a period of lessened loading, such as bed rest. Muscle, tendon, and cartilage all 
experience similar dynamic mechanical cues.52 It has been shown that both alignment cues and 
mechanical stimulation can synergistically drive mesenchymal stem cells towards a tenogenic 
fate.53 Biomaterials for complex musculoskeletal repair applications must therefore present pore 
size, shape, and stiffness cues to create a complex microenvironment which drives cellular 
behavior. 
 
1.3: Strategies to Create Porous Biomaterial Scaffolds 
Porous biomaterials need to incorporate pore size, shape, and stiffness into a construct which not 
only promotes cellular viability, but provides biophysical and microenvironmental cues to 
regenerate entire tissues. There are many techniques to create porous biomaterial scaffolds, all 
with their (often application-specific) advantages and disadvantages. Here we will focus on the 
most popular techniques to create porous biomaterial scaffolds for tendon and bone regeneration.  
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1.3.1 Salt leaching and colloidal crystal templating 
One way to create a porous structure is by starting with a suspension of solid particles which are 
later removed to form pores. Colloidal crystal templating is a technique which starts with 
colloidal particles, which are then ordered typically via centrifugation, drying, or sedimentation 
into crystalline arrays. A second substance, which will become the bulk biomaterial, is used to 
fill in the space between particles, and the crystalline array is dissolved to leave a porous, highly 
ordered structure behind. Although the pores in this technique are consistent and highly ordered, 
harsh solvents are often used to dissolve the template (i.e. HF, toluene), which are concerns for 
biological applications. The pores in this technique typically range from 1 to 100 µm, depending 
on the size of the crystalline template.31,54-56 (Figure 1.4(A)) 
 
Salt leaching is a relatively similar technique, but instead of using colloids to form crystals, salt 
is used. In this technique, salt crystals are added to a polymeric solution. The substrate is either 
polymerized or the fibers aggregate to form a solid. The salt crystals are dissolved in an aqueous 
solution and the final construct is dried, leaving a porous material behind. The pores left by the 
salt crystal typically range from approximately 400 to 1000 µm.32 One limitation to this 
technique is that the polymer must be either non-aqueous, or must aggregate into a solid in the 
presence of salt. 
 
1.3.2 Lyophilization 
Another way to create a porous scaffold is through a lyophilization process commonly known as 
freeze-drying. Lyophilization consists of freezing, then sublimating the ice crystals through a 
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drop in pressure, which leaves behind a dry, porous construct. Pore size, which is dependent on 
ice crystal formation and can be controlled by adjusting the freezing temperature, is typically 
between 50 µm and 300 µm.29,30,57 Pore alignment can also be integrated by using a directional 
solidification technique, creating highly aligned pores that can help drive stem cells down a 
tenogenic lineage.58-60 Lyophilization requires an aqueous suspension, which can be mineralized 
to support bone formation. This technique is extremely versatile, increases the shelf life of the 
construct, and maintains biological and chemical activity.61 (Figure 1.4(B,C)) 
 
1.3.3 Electrospinning 
Although templating and lyophilization are techniques that remove parts of the construct to 
create pores, there are also techniques which rely on forming pores as the material is created. 
Electrospinning is a technique which uses mutual charge repulsion in a polymer to accelerate a 
jet of nanofibers from a nozzle to a grounded substrate. If the distance from the nozzle to the 
substrate is large enough, instabilities will form within the liquid stream, which causes random 
coils and produces a spun, nanofibrous mat.62,63 Fiber alignment can be incorporated into this 
technique by moving the grounded substrate to a rotating drum.64,65 Fibers can also be co-spun, 
so that the final material is a mixture of multiple fibers instead of being homogenous.66 In 
electrospinning, fiber diameter typically ranges from 10 to 500 nm while pore diameter is 
approximately 100 nm to 10 µm. Although electrospinning is quite versatile, it is limited to 
either shear-thinning materials or polymers which can be jetted, then hardened or cross-linked 
once they have left the nozzle. There is also a limit to how thick the nanofibrous mat can become 
(typically around 1 mm) before the resistance surpasses the voltage required to electrospin, 
making this essentially a 2D technique.33,67 (Figure 1.4(D)) 
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1.3.4 3D Printing 
It is also possible to obtain a porous biomaterial by printing a polymeric or shear-thinning 
solution layer by layer using computer-aided 3D printing. In this method, the pore size is limited 
by the resolution of the printer, which is typically on the order of 100 - 1000 microns.34 Although 
nearly any shape is possible to print, there is usually a small loss in pattern fidelity and printing 
is somewhat time consuming. However, 3D printers are becoming more commonly available, 
less expensive, and faster, which will greatly impact their wide-spread use.34,68-70 (Figure 1.4(E)) 
 
1.4: Material Choice for Porous Scaffolds 
The ECM provides structural support, biomolecular sequestration, and a microenvironment in 
which cells can live and interact.71 These are the properties which a biomaterial scaffold is meant 
mimic. Although cells receive biophysical information from the microenvironment of the porous 
biomaterial they are within, the biochemistry of the scaffold is very important as well. Most 
materials employed in tissue engineering are meant to mimic the ECM, which is a complex 
combination of macromolecules and proteins, often arranged in a hierarchal structure.72 
 
Tendon and bone both consist of approximately 90% ECM.73 The ECM in tendon is primarily 
composed of collagen (predominantly type I) and elastin and is notably structured in a complex 
hierarchy. Collagen molecules are the most basic unit of this hierarchy. Collagen molecules 
(~1.5 nm) come together to create collagen fibrils (~50-500 nm), which then make up tendon 
fascicles (~50-100 µm), which are crimped to form the macroscopic tendon structure (Figure 
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1.5)3. Although a large percent of bone is also composed of collagen, approximately 80 % of 
bone by weight is also mineralized with calcium hydroxyapatite.73  
 
1.4.1 Hydroxyapatite ceramics 
As previously mentioned, bones primarily consist of calcium phosphate, in the form of 
hydroxyapatite, and type I collagen.74 Hydroxyapatite can easily be incorporated into a bioactive 
ceramic, which has been shown to induce osteogenesis in mesenchymal stem cells. Ceramic 
materials can be created to have pores on the microscale, which allows for cellular infiltration 
and nutrient transport, both which are needed for bone regeneration.75 Ceramics, although brittle, 
can also closely mimic the mechanical properties of bone, which is especially important in bones 
which provide structural support to the skeleton. Overall, ceramics are an attractive material for 
use as a bone substitute, or as a scaffold to regenerate bone (Figure 1.4(F)).  
 
1.4.2 Decellularized ECM 
Instead of trying to design and manufacture new materials to mimic the ECM, decellularized 
ECM utilizes the existing components of native tissues. In this method, tissue is taken from a 
donor and the existing cells are lysed and washed away, leaving only the ECM components 
behind. Although this technique has shown great potential76-79, it requires a tissue donation and it 
is very difficult to completely remove all of the native cells, which may lead to a negative 
immune response in the patient. Whether the limitations of using an allogenic biomaterial 
outweigh the benefits of an exact ECM structural replica remain an open question for 
consideration. (Figure 1.4(G)) 
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1.4.3 Collagen 
Collagen is a dominant ECM protein found in a wide variety of tissues. Another group of 
compounds commonly found in connective tissues are proteoglycans, core proteins decorated 
with charged glycosaminoglycans. Collagen-glycosaminoglycan (CG) scaffolds are a versatile 
choice not only for tendon and bone tissue engineering, but also for many other collagen-
containing tissues (i.e. tendon2,80,81, bone82-84, cartilage82,85,86, eye, skin87,88, and vasculature89). A 
very successful CG-based scaffold, INTEGRA® Dermal Regeneration Template, has already 
been developed and approved by the FDA for dermal regeneration. Many CG scaffolds are based 
off of the same FDA approved biomaterial, which lessens some of the hurdles in moving from 
bench top to clinical trials. Biomolecular and biophysical cues can easily be incorporated into 
CG scaffolds as well. Hydroxyapatite can be included into the CG scaffold for bone tissue 
engineering82,90, and it is established that biomolecules can be cross-linked58 or patterned91 into 
the scaffold as well. CG scaffolds are a versatile material for a number of different applications. 
(Figure 1.4 (B,C)) 
 
1.4.4 Hydrogels 
Another approach to generate a 3D microenvironment for cells is to encapsulate them within a 
hydrogel. Many materials (polyacrylamide92-94, alginate95-97, gelatin98-101, poly(ethylene glycol) 
or PEG-based100,102-104, among others101,105) can be used for this and they are extremely versatile. 
By changing the material itself, many different chemistries can be utilized within a hydrogel. 
Varying cross-linking and material densities of hydrogels can cause drastic changes in 
mechanical properties as well.92,105,106 Factors can be easily incorporated into hydrogels through 
crosslinking, and research into injectable, noninvasive methods of delivery are currently being 
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explored.107 While hydrogels are being extensively researched, they are the least porous of the 
materials discussed. Cells cannot be directed seeded on them and must be incorporated into the 
pre-gel state. Cells must therefore remodel their environment in order to move throughout the gel 
or migrate into it. While this is a feasible material to regenerate some tissue types, this 
remodeling process must be carefully controlled for structural tissues such as tendon and bone. 
Figure (1.4(H)) 
 
1.5: Incorporation of Biomolecular and Biophysical Cues 
Although the chemistry and pore structure of biomaterial scaffolds play an important role in 
cellular behavior, biomolecular (i.e. growth factor, protein) supplementation and additional 
biophysical cues can be incorporated into scaffolds to elicit a more specific or enhanced 
biological response. Cells in the human body are constantly receiving and integrating cues from 
an assortment of solution phase29,58,95,108-113 and substrate-supported114-119 stimuli that influence 
their behavior. Solution phase signals mostly consist of growth factors, but can also consist of 
paracrine, endocrine, and other small bioactive molecules. In the human body, the ECM is the 
primary substrate within which cells carry out their specific tasks. Untangling the intricate 
correlations between cellular signals and the resulting cellular responses is often complicated and 
is a driving force in developing next generation instructive materials.  
 
1.5.1 Solution phase biomolecular presentation 
Cells are constantly receiving and integrating a number of complex cues from a variety of 
growth factors in vivo. One way to deliver growth factors to cells in vitro is to supplement the 
cellular media with soluble growth factors. However, cellular response to soluble factors is 
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dependent on solution-phase dynamics, such as the diffusion rate of the factor, the metabolic 
activity of the target cells, and the local concentration of the factor.120 Soluble factor 
supplementation has had some success in a variety of applications. Notably, in our research 
group, Caliari et al. demonstrated enhanced tenocyte chemotaxis (by insulin-like growth factor-
1, or IGF-1 supplementation) and proliferation (by PDGF-BB supplementation) in a dose 
dependent manner29, and went on to show that multiple growth factors could elicit synergistic 
cellular responses in proliferation and differentiation.121 Borselli et al. showed a similar 
synergistic response in muscle cells with combined delivery of angiogenic and myogenic growth 
factors.95 Critically, there are often trade-offs in stem cell proliferation and differentiation, which 
suggests that multiple cues may need to work in tandem to elicit the desired response. There 
have been a number of studies using growth factors as cues to direct human mesenchymal stem 
cell (hMSC) or adipose derived stem cell (ASC) fate. Notably, Tan et al. demonstrated that 
GDF-5 induced tenogenic differentiation in MSCs without negatively impacting proliferation122, 
while other studies have looked at multiple cues to promote proliferation (i.e. PDGF) and 
tenogenesis simultaneously.113,123  
 
1.5.2 Substrate supported biomolecular cues 
While soluble factor presentation is an effect method of delivery in vitro, this method is limited 
in vivo by diffusion away from the target site. Lack of localization also increases the probability 
that the growth factor will affect unintended targets, such as other cell types or tissues. 
Furthermore, there is evidence immobilization of growth factors may even enhance activity, as 
this is how these signals are often presented within the ECM.124,125 To this end, many research 
groups have immobilized growth factors to scaffolds using a variety of methods (carbodiimide 
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cross-linking88,97,116, biotin-avidin linkages126, and “click” chemistries127, among others), but lack 
the ability to control spatial distribution of these biomolecules.  
 
One method to create spatially selective cues is through photolithography. In this method, 
biochemical cues are covalently attached to a substrate via a photoinitiator. Since the cues are 
only covalently bound when exposed to light, a photomask of any shape or pattern can be used to 
functionalize the material in a spatially selective manner.91,117 In our group, Martin et al. 
demonstrated the ability to pattern multiple factors on a single substrate using Benzophenone 
photolithography.91 Another way to create spatially selective cues is to incorporate them in the 
material itself, pre-fabrication. These molecules can either be incorporated into the raw materials 
non-covalently124,128, by covalent attachment92,97,129-131, or through nano- or micro-
encapsulation.103,108,132,133 Notably, Min et al. demonstrated the ability to non-covalently 
incorporate gradients of PDGF-BB and BMP-2 into a 2D membrane through a pre-fabrication, 
diffusion based method for tendon to bone repair. They found differential cell phenotype across 
the membrane, with a more tendon-like phenotype on the PDGF side and a more bone-like 
phenotype on the BMP-2 side. However, they lack the ability to expand this technique to 3D 
systems.134 Separately, Buket et al. investigated sequential BMP-2 and BMP-7 delivery from 
microspheres incorporated into their scaffold and found that while temporal release did not 
encourage additional osteogenic differentiation, co-delivery of these two GF produced 
synergistic cellular response.108 The ability to present biomolecular cues in a spatiotemporal 
manner adds an additional degree of control to factor supplementation that is particularly 
attractive for orthopedic interface repair applications.  
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1.5.3 Incorporation of biomechanical cues 
Stem cells not only respond to biochemical cues, but are particularly sensitive to the mechanics 
of their local microenvironment as well.48,92,129,135 Recent advancements in biomaterials have led 
to increasingly complex emulation of the ECM, which can provide additional cues for stem cells 
to differentiate, proliferate, or remain quiescent. However, independent control of mechanical 
properties in a biologically relevant substrate has proven to be challenging. Traditional materials 
have inherent difficulty elucidating an independent response while simultaneously changing the 
stiffness of the material. For example, traditional hydrogel materials change in pore size, relative 
density, side-chain exposure, and immobilized factor presentation when cross-linked to a 
significantly higher mechanical stiffness.28 Electrospun scaffolds typically increase mechanical 
stiffness by increasing the thickness of each spun fiber, which concurrently decreases pore size.33 
Changing the stiffness of a material by changing its composition can also expose cells to a 
different and undesirable microenvironment. 
 
Mechanical stimulation in the form of static or cyclic strain can also be used as a cue to drive 
stem cell response. Hsieh et al. established a method in which to create a gradient strain profile 
in which fibroblasts aligned themselves in the direction of strain. However, cyclic strain is a 
biologically relevant cue in the musculoskeletal system. Multiple research groups have shown 
that cyclic strain produces a tendon-like phenotype in MSCs.136,137 
 
By combining biomolecular supplementation and incorporating biophysical cues with specific 
scaffold chemistry and pore structure, we may be able to develop synthetic biomaterials which 
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can elicit a range of discrete responses from a single (stem) cell type. Our goal is to combine 
physical and chemical attributes into a single construct for TBJ regeneration. 
 
1.6: Our Approach to Creating a Multi-Compartment Scaffold for TBJ Regeneration 
There are many challenges in designing a biomaterial to regenerate monolithic tissues such as 
tendon and bone. However, these challenges are confounded when the target tissue is 
heterogeneous. Not only must the material incorporate cues to regulate tissue-specific responses, 
but we hypothesize that the material must present these cues in a spatially selective manner. 
Additionally, new design criteria—particularly at the interface—are introduced when the 
material is intended for multi-tissue purposes. 
 
1.6.1 Strategies to fabricate a multi-tissue biomaterial 
Multi-tissue biomaterials should provide different cues to different compartments, which will be 
used to regenerate different tissues, or even a single tissue with heterogeneity throughout. 
Although there are a variety of materials and methods to create scaffolds for tendon and bone 
regeneration, not all of them are easily adapted into a multi-compartment construct. 
 
One key consideration in creating multi-compartment biomaterials is physical compatibility—
that the individual scaffold compartments will remain functional and intact post-fabrication—and 
mechanical compatibility—that both compartments of the scaffold remain continuous under 
physiologically relevant strain. The easiest way to ensure physical compatibility is to be able to 
use the same method of creation on both compartments. For example, hydrogels, electrospinning, 
and lyophilization techniques have all successfully demonstrated gradients across a single 
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construct.53,138,139 However, complexities arise when using other methods. For example, a highly 
porous ceramic for bone tissue engineering may not easily be incorporated with a hydrogel into a 
multi-compartment scaffold. Ceramics are typically constructed under high temperatures, which 
would destroy a hydrogel. If the ceramic was created first to mitigate these limitations, care must 
be taken to ensure that the hydrogel does not infiltrate the pores of the ceramic in places meant 
for bone tissue engineering. While these challenges are not insurmountable, they are limitations 
to creating an easily mass produced, “off the shelf” product for multi-tissue regeneration.  
 
Each compartment must also be integrated into a continuous construct that can withstand the 
mechanical in vivo forces the tissue typically experiences. For a material designed to regenerate 
the TBJ, the material must be able to closely mimic the mechanical properties of tendon, bone, 
and be able to transmit tensile loads across the junction without failure. The junction between 
any two mechanically dissimilar materials experiences high stress concentrations.140 In nature, 
stress concentrations can be dissipated through interdigitation, such as those found in 
arapaima,141-143 turtle shells144, and the native rotator cuff1 (Figure 1.1(B), Figure 1.6).  
 
Our approach to developing a multi-compartment scaffold is through co-lyophilization of a CG 
and a mineralized CG (CGCaP) suspension to create a CG-CGCaP construct. Our lyophilization 
process consists of freezing both suspensions at a specific temperature (typically from -10 °C to -
60 °C which correlates to a specific pore size), followed by a sublimation step (200 mTorr) in 
which the ice crystals are removed, leaving a dry, porous, sponge-like material behind (Figure 
1.7). Through this method, we have the ability to maintain many of the biochemical and 
structural properties of collagen and chondroitin sulfate, in addition to any other components we 
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wish to incorporate into the substrate. Furthermore, a lyophilization process is easy to adapt to 
multi-compartment scaffolds. Since both compartments are made from CG-based suspensions, it 
is relatively easy to simply combine the two liquid suspensions and allow a small amount of 
diffusion to ensure a continuous interface. 
 
1.6.2 Strategies to incorporate spatially selective multi-tissue biochemical cues 
In order to stimulate a multi-compartment scaffold with tissue-specific biochemical cues, we 
hypothesize that these cues must be spatially selective. Substrates modified with the 
photoinitiator benzophenone (BP) provide the ability to generate arbitrary and spatially 
controlled patterns of covalently immobilized proteins using ultraviolet (UV) light.91,145 A 
particularly important element of this technology is that unreacted BP can relax to back to its 
ground state, allowing it to be re-excited in the presence of a separate biomolecule of interest to 
facilitate sequential covalent immobilization of multiple biomolecules. This process can be used 
to incorporate multiple, covalently attached biochemical cues into a multi-compartment scaffold 
for TBJ regeneration. 
 
1.7: Thesis Organization 
In this chapter, we discussed TBJ injuries and current strategies to surgically repair these injuries 
as motivation for this project. We then turned to a general tissue engineering approach, which 
was discussed in detail from methods of scaffold fabrication, to biomaterials for scaffold 
creation, to various ways of functionalizing these materials. The remainder of this thesis will 
further establish the design of a multi-compartment CG-CGCaP scaffold for TBJ regeneration, 
which was introduced in this chapter. Chapter 2 will describe the mechanical and biophysical 
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characterization of these multi-compartment scaffolds. Chapter 3 will look at compartment-
specific cellular response (nuclear aspect ratio, nuclear orientation, actin alignment) across multi-
compartment scaffolds after strain. Chapter 4 will look at cellular response (proliferation, gene 
expression) to patterned growth factors (BMP-2, PDGF-BB) and varying elastic modulus (~3, 4, 
and 5 MPa), which we have the ability to orthogonally control. Finally, chapter 5 will conclude 
with a summary of the thesis, and a proposal for future work.   
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1.8: Figures 
 
 
 
Figure 1.1: Visualization of the spatial heterogeneities across the TBJ. (A) The TBJ consists of 
spatial gradients of matrix proteins, alignment, and growth factors. (B) The structural anatomy of 
the TBJ at the rotator cuff consists of tendon and bone bound together by interdigitating 
unmineralized and mineralized fibrocartilage. Figure adapted from1-3,146 
  
A B 
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Figure 1.2: Typical surgical repair methods for a torn rotator cuff. (A) The anatomy of a healthy 
rotator cuff, which is a portion of the shoulder. (B) A torn rotator cuff is shown, where the 
tendon has ripped away from the bone after injury. (C) A typical repair of the rotator cuff after 
injury. The sutures attach the tendon to holes which are drilled into the bone.12 
  
A 
B 
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Figure 1.3: Typical surgical repair methods for a torn ACL. (A) The anatomy of a healthy ACL, 
which typically tears at the knee. (B) The patellar tendon is typically the site where a tendon 
graft is harvested, leaving donor site morbidity which often causes pain after surgery. Sections of 
bone are left on both ends of the patellar graft for reattachment purposes (C) The repaired ACL 
using the patellar tendon graft. In order to attach the tendon graft, holes are drilled into the bone 
and screws are used to hold the graft in place.27 
  
A 
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Figure 1.4: Methods of biomaterial fabrication. (A) Colloidal template using gold nanoparticles31 
(B) Mineralized CG lyophilized scaffold147 (C) Anisotropic CG lyophilized scaffold147 (D) 
Electrospun anisotropic PLA fibers33 (E) 3D Printed PLA scaffold34 (F) Calcium phosphate 
ceramic75 (G) Decellularized tendon ECM79 (H) N-isopropylacrylamide hydrogel105  
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Figure 1.5: Hierarchal structure of collagen. Collagen molecules are arranged in a hierarchal 
structure which helps to impart mechanical bulk mechanical characteristics.3 
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Figure 1.6: Bioinspired interdigitating interfaces. (A) The shell of a turtle is interdigitated where 
the plates meet one another. This allows for regular movement and respiration, while 
maintaining the strength and protection that is required144 (B) An SEM image where the plates of 
the turtle shell meet one another.144 (C) Arapaima, a type of armored fish, also utilizes 
interdigitation in its scales.142 (D) Close up of an arapaima scale, showing the interdigitation on 
the external layer of the scale.142 
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Figure 1.7: Fabrication schematic for CG and CGCaP scaffolds. Two suspensions, one consisting 
of type I collagen, chondroitin sulfate, and acetic acid and the other consisting of type I collagen, 
chondroitin sulfate, calcium salts, and phosphoric acid, are homogenized. The homogeneous 
suspensions can then be taken through a lyophilization process, which consists of a freezing step 
followed by sublimation. This leaves a dry, porous, sponge-like scaffold. 
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CHAPTER 2: CREATION AND CHARACTERIZATION OF MULTI-
COMPARTMENTAL CG-CGCAP SCAFFOLDS 
2.1: Introduction 
Ideally a biomaterial based scaffold for tissue regeneration should have similar mechanical 
properties to the native, healthy tissue it is replacing. However, there is also a trade-off between 
mechanics and cellular viability. Cellular viability and nutrient transport increase with increasing 
porosity, whereas scaffold mechanical properties decrease with increasing porosity.28 Since the 
CG scaffolds our group has developed are highly porous, their mechanical properties do not 
match that of tendon and bone.60 Although other work in our group has been exploring ways in 
which to increase the bulk mechanical properties of our scaffolds via a core-shell paradigm42,81, 
the work in this chapter focuses on characterizing both the bulk and interfacial mechanical 
properties of our CG-CGCaP multi-compartment scaffolds.  
 
Although bulk failure is a concern, stresses are also concentrated at the interface of any multi-
compartment material where the mechanical properties are mismatched. The native TBJ in the 
rotator cuff dissipates these stresses through a mineral gradient and an interdigitated 
interface.148,149 This general form of interdigitation has been considered and modeled in the 
design of structural materials,140 but has yet to be translated to biomaterial applications. Across a 
periodically repeating interdigitation, the amplitude (A), period (λ), interfacial thickness (g), 
minimum contact length (lo), and actual contact length (l) can all impact interfacial shape (Figure 
2.1(A)). However, Li et al. demonstrated that these variables can all be reduced down to two 
components: the suture complexity index (SCI) and the angle of interdigitations (Θ). The SCI is 
a measure of contact length across the interface, l divided by lo. Θ determines how many 
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interdigitations, or “teeth” can fit across the interface. Li et al. also showed that there is an ideal 
Θ (approximately 12o in their model system) where tensile forces applied across the interface 
fundamentally shift to shear forces, which can be distributed over a larger area and thus 
minimized. 140  
 
Our goal is to demonstrate the potential of an interdigitated multi-compartment biomaterial to 
create a mechanical stable interface in a biomaterial under development for TBJ repair. The work 
in this chapter focuses on creating an interdigitated interface within a CG-CGCaP multi-
compartment scaffold. We also demonstrate a strategy in which to manipulate the mineralized 
gradient across the scaffold. Finally, we characterize the bulk tensile properties of interdigitating 
CG-CGCaP scaffolds and demonstrate strategies in which to measure the mineral gradient and 
mechanical properties across the interface of multi-compartment CG-CGCaP scaffolds.  
 
2.2: Materials and Methods 
2.2.1 CG Suspension Preparation 
A CG suspension was prepared from type I collagen (1.0% w/v) isolated from bovine dermis 
(Sigma-Aldrich, St. Louis, MO) and chondroitin sulfate (0.1% w/v) derived from shark cartilage 
in 0.05 M acetic acid. The suspension was homogenized at 4 °C to prevent collagen 
gelatinization during mixing and was degassed before use. 
 
2.2.2 CGCaP Suspension Preparation 
A CGCaP suspension was prepared from type I collagen (1.93% w/v) isolated from bovine 
dermis (Sigma-Aldrich, St. Louis, MO) and chondroitin sulfate (0.84% w/v) derived from shark 
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cartilage in 0.1456M phosphoric acid / 0.037M calcium hydroxide buffer solution. The 
suspension was homogenized at 4 °C to prevent collagen gelatinization during mixing. Calcium 
salts (Ca(OH)2) and Ca(NO3)·4H2O) were added during homogenization and suspension was 
degassed before use. This suspension has previously been shown to produce 40 wt% mineral 
scaffolds by a titrant-free concurrent mapping method.150 
 
2.2.3 Layered scaffold creation with interdigitated interfaces 
Custom aluminum molds (5”x5”) with a removable divider of varying degrees of interdigitation 
– flat interface, 1 intedigitated tooth, 2 intedigitated teeth across each sample (1.67” wide) – were 
filled with CG suspension (46.1 mL) in one compartment and CGCaP suspension (46.1 mL) in 
the other. The suspension-loaded mold was placed on a freeze-dryer shelf (VirTis, Gardiner, NY) 
at 20 °C, the divider was removed, and the desired amount of diffusion (0 hr, 2 hr) was allowed. 
The shelf temperature was then ramped down to -40 °C at a rate of 1 °C/min and held at -40 °C 
for 1 hour to ensure complete freezing. Following freezing, the shelf temperature was ramped up 
to 0 °C at a rate of 1 °C/min while pulling a 200 mTorr vacuum to remove ice crystals via 
sublimation. For absolute 0 hour diffusion scaffolds, the CG suspension was frozen at -40 °C and 
then the divider removed. The CGCaP suspension was then added and the freeze dryer shelf was 
warmed to 20 °C to allow minimal diffusion and prevent delamination between compartments. 
The shelf temperature was then ramped down to -40 °C at a rate of 1 °C/min and held at -40 °C 
for 1 hour to ensure complete freezing. Following freezing, the shelf temperature was ramped up 
to 0 °C at a rate of 1 °C/min while pulling a 200 mTorr vacuum to remove ice crystals via 
sublimation (Figure 2.2). 
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2.2.4 Mineral content characterization via SEM/EDX 
Mineral content was visualized via scanning electron microscopy (SEM) and energy dispersive 
X-ray spectroscopy (EDX). SEM/EDX was performed using a JEOL JSM-6060LV Low 
Vacuum Scanning Electron Microscope (JEOL USA, Peabody, MA) using backscatter electron 
(BSE) detection under low vacuum. EDX was used to acquire compositional visualization of 
calcium (Ca) and phosphorus (P) content within interdigitated (flat, 1 tooth, 2 teeth) CG-CGCaP 
samples.  
 
2.2.5 Mineral gradient characterization via µCT 
Micro-computed tomography (µCT) analysis was performed using a Xradia MicroXCT-400 
(Xradia, Pleasanton, CA) at 25 kEv and 5 W. The interface between the CG scaffold and CGCaP 
scaffold was scanned at voxel size of 5 µm3. The interface width was determined by stacking an 
exported series of tiff images in the XY plane and performing a line scan in the mineral and non-
mineral compartment to determine baseline values. Line scans were then performed across the 
interface. The first data points with an average intensity 2 standard deviations (σ) above the non-
mineral baseline mean or 1.5 σ below the mineral baseline mean were considered to be the 
interfacial zone. The width of this zone was then measured every 10 pixels across the interface, 
excluding the edges of the tiff series 
 
2.2.6: Mechanical (tensile) characterization 
Layered CG-CGCaP scaffolds (1.5” width, 0.25” thickness, 3” gauge length) with varying 
interdigitated interfaces (flat, 1 tooth, 2 teeth) underwent mechanical testing in an MTS Insight 
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electromechanical load frame (250 N). Samples were held in place with rubberized grips to 
prevent slip. Scaffolds were strained at a rate of 1 mm/min until failure. Elastic modulus was 
calculated as the slope of the linear elastic region of the stress-strain curve and failure load was 
taken as the peak load the sample experienced before failure.  
 
2.2.7: Microindentation  
Indentation of multi-compartment CG-CGCaP scaffolds was performed with an Instron 5500 
series load frame (Instron, Canton, MA) in displacement control using a 2.4-mm-diameter 
stainless steel spherical tip and a ramp-hold relaxation profile. The testing profile consisted of a 
1-s ramp to an indentation depth of 0.075 mm followed by a 30-s hold during which stress 
relaxation was assessed and compressive elastic moduli were calculated (for comparison with 
tensile data) using the peak load occurring at the end of the 1-s ramp period, using the Hertzian 
elastic contact formula. Tests were performed in an offset grid pattern, such that 3 tests were 
performed at the same distance from the interface and a minimum of 700 µm separation was 
maintained between the edge of the scaffold and any other indent (far in excess of the indenter 
contact radius of approximately 200 µm) A total of 60 indentations were made per sample, with 
3 samples per group. 
 
2.2.8: Statistics  
One-way analysis of variance (ANOVA) was performed on mineral gradient characterization via 
µCT, mechanical (tensile) characterization, and microindentation tests, followed by Tukey post-
hoc tests. Significance was set at p<0.05 and n=3 for all groups. Error is reported as standard 
deviation unless otherwise noted. 
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2.3: Results 
2.3.1 Mineral content characterization via SEM/EDX 
Layered scaffolds with interdigitated interfaces (flat, 1 tooth, 2 teeth) were visualized. While 
BSE images show an outline of the interface for each sample type, Ca and P were expressly 
visualized via EDX as well. Ca and P were only seen in the mineral compartment of the scaffold 
and the geometry of each interface can clearly be seen qualitatively (Figure 2.3). 
 
2.3.2 Mineral gradient characterization via µCT 
The mineral gradient was characterized via µCT in flat interface samples of varying diffusion 
time (Absolute 0, 0 hr, and 2 hr). For each sample, stacks of images were compiled to create a 
high resolution image representative of the full depth of the sample. Baseline measurements were 
taken in fully mineralized and fully non-mineralized compartments of the sample and then line 
scans were drawn across the interface. The interface was determined to be where the intensity of 
the line scan increased 2 standard deviations (σ) above and 1.5 σ below the baseline 
measurements for CG and CGCaP compartments, respectively. This distance was then measured 
to find the interfacial width. In the XY plane, there were no differences in interfacial width 
between groups (Figure 2.4(A)). However, through µCT, we were able to visualize how the 
mineral and non-mineral compartments were mixing. The mineral compartment typically 
diffused across the bottom the scaffold, or in a u-shaped interface, which may be a phenomena 
related to removing the divider instead of actual diffusion time. Therefore, we analyzed the YZ 
plane as well. However, there were still no differences between groups (Figure 2.6(B)). In the 
XY plane, the interface was found to be 208 ± 20 µm (absolute 0), 264 ± 113 µm (0 hr 
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diffusion), and 216 ± 41 µm (2 hr diffusion), with no significant differences between groups 
(Figure 2.7(A)). In the YZ plane, the interface was found to be 165 ± 45 µm (absolute 0 
diffusion), 179 ± 48 µm (0 hr diffusion), and 151 ± 19 µm (2 hr diffusion), with no significant 
differences between groups (Figure 2.7(B)). Error is reported as standard deviation. 
 
2.3.3: Mechanical (tensile) characterization 
Multi-compartment scaffolds with increasing degrees of interdigitations (flat, 1 tooth, 2 teeth) 
across the interface were loaded in tension. With increased interdigitation, the elastic modulus 
significantly increased (flat: 230.2 ± 5.9 kPa; 1 tooth: 241.6 ± 64.8 kPa; 2 teeth: 396.7 ± 39.5 
kPa). Furthermore, an increase in interdigitation caused the failure load to increase significantly 
as well (flat: 8.4 ± 0.5 kPa; 1 tooth: 7.1 ± 0.9 kPa; 2 teeth: 12.5 ± 0.87 kPa). The 2 tooth 
interdigitated geometry displayed the highest mechanical properties, even though the bulk 
materials were the same across all groups (Figure 2.6). 
 
2.3.4: Microindentation  
Microindentation was performed in collaboration with Michelle Oyen’s lab on flat interface 
multi-compartment scaffolds of varying diffusion time (absolute 0, 0 hr, and 2 hr). An algorithm 
which back-calculates the expected interfacial width which would produce the measured gradient 
of strain fields was run on all samples. Although we expected that with increased diffusion time, 
there would be an increased interfacial width, we were not able to see any significant differences 
between samples. However, there is a significant mechanical difference between the mineralized 
and non-mineralized compartments of the scaffold (Figure 2.7). 
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2.4: Conclusions and Future Directions 
Throughout this chapter, we have demonstrated a novel method to create multi-compartment 
interdigitated scaffolds, with a mineralized compartment on one side and a non-mineralized 
compartment on the other. We have shown that we can localize mineral content to one 
compartment of the scaffold and have developed an analysis method to measure the length of the 
interface and the diffusion of mineral content across the interface. Furthermore, we have shown 
that interdigitation increases the elastic modulus and failure load of CG scaffolds in tension, 
which supports theoretical work performed by other research groups.140 
 
Additional experiments will explore how these materials perform mechanically after biological 
remodeling has taken place. We are interested not only in how mechanical properties of the bulk 
compartments change, but how cells behave and remodel the very thin interstitial zone between 
compartments. We have yet to characterize pore size and structure across the interface of our 
multi-compartment scaffolds as well, which can drastically affect cellular activity. We 
hypothesize that the graded mineral content and pore structure will elicit a cellular response more 
similar to that found at the TBJ. 
 
Interestingly, µCT analysis found no significant differences in interfacial width between samples 
with increasing diffusion time. However, further analysis which does not rely on depth-averaged 
images will be performed and may help resolve differences in interface width more accurately. 
No significant difference in graded microscale mechanical properties was found either, though 
improved analysis will be possible with improved resolution of mineral gradients across the 
interface and is the subject of ongoing work. However, we have shown that our layered scaffolds 
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display a continuous interface and that the interfacial zone is approximately 200-250 µm wide, 
which is consistent with the native rotator cuff (~0.1 to 1 mm depending on species)4,151,152. 
Future work will be done to explore expanding the size of this zone.  
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2.6: Figures 
 
Figure 2.1: Key components in theoretical modeling of interdigitated interfaces. (A) There are 
many components which can be measured across the interface which describe its degree of 
interdigitation, including the amplitude (A), period (λ), thickness (g), minimum contact length 
(lo), and actual contact length (l). (B) However, the strength of interdigitated interfaces can be 
simplified to just two components, the suture complexity index (SCI) and the angle of 
interdigitations. The SCI is a measure of contact length across the interface, l divided by lo. The 
angle of interdigitation (Θ) is important for two reasons. First, Θ determines how many 
interdigitations, or “teeth” can fit across the interface. There also exists an ideal Θ where tensile 
forces applied across the interface fundamentally shift to shear forces, which can be distributed 
over a larger area and thus minimized. 140 
  
A 
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Figure 2.2: Fabrication schematic for interdigitated CG scaffolds. (A) In order to fabricate multi-
compartment scaffolds, a custom mold with a removable, interdigitated divider was used. Each 
compartment was filled with either a CG or a CGCaP suspension. The divider was removed and 
a set amount of diffusion time was allowed prior to lyophilization. (B) In this manner, we can 
create interdigitated scaffolds with varying degrees of complexity across the interface. 
  
A 
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Figure 2.3: Visualization of mineral content across interdigitated scaffolds. SEM scans were 
taken to confirm the presence of mineral (calcium and phosphorous) content isolated to the 
mineralized compartment of the CG-CGCaP scaffold. Shown above is a cartoon representation 
of each sample, followed by representative images from a flat interface, one tooth, and two teeth 
scaffolds. Only one of the two teeth was visualized in the two teeth scaffolds. 
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Figure 2.4: Characterization of mineral content across an interdigitated interface. Using µCT, 
stacks of images were compiled to create a high resolution image representative of the full depth 
of the sample. Baseline measurements were taken in fully mineralized and fully non-mineralized 
compartments of the sample. Line scans were drawn across the interface. The interface was 
determined to be where the intensity of the line scan increased 2 standard deviations (σ) above 
and 1.5 σ below the baseline measurements for CG and CGCaP compartments, respectively. This 
distance was then measured in both the XY (A) and YZ (B) planes. 
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Figure 2.5: Interfacial width quantified via µCT. (A) The mineral gradient was found to be 
slightly larger in the XY plane, ~200-250 µm wide. (B) In the YZ plane, the interface is slightly 
smaller at ~150 µm wide. 
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Figure 2.6: Mechanical properties of interdigitated scaffolds. Mechanical strength increases as 
the degree of interdigitation increases (A) Representative stress-strain curve of interdigitated 
scaffolds. (B) Increase in elastic modulus with increased interdigitation. (C) Increase in failure 
load with increase in interdigitation. *significantly greater than all other samples (p<0.05, n=5). 
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Figure 2.7: Mechanical properties across the interface of multi-compartmental scaffolds. 
Although we expected to see a steeper gradient in elastic modulus across the interface as we 
decreased diffusion time, all groups showed the same micro-mechanical properties. We hope to 
elicit additional information as we further explore the mineral content gradient across the 
interface. 
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CHAPTER 3: HMSC CULTURE AND OBSERVED RESPONSE TO STIMULI 
3.1: Introduction 
The musculoskeletal system of the human body consists of loading bearing tissues (muscle, 
tendon, bone) which experience strain on a daily basis. After injury, these tissues are no longer 
able to bear the same load until healed, either partially or fully. However, previous studies have 
shown that mechanical stimuli early in the healing or development-stage of new tissue formation 
is crucial.153 Although cyclic strain has been studied more widely52,137,154-157, static strain has also 
been shown to induce cellular response (morphology, alignment) in biomaterials.106,158,159 
 
This chapter describes cellular response (nuclear aspect ratio, nuclear orientation, actin 
alignment) to static, overnight strain (0%, 11%, 20%) on two multi-compartment scaffold 
variants (osteotendinous, layered). The osteotendinous CG-CGCaP scaffold has aligned pores in 
the CG compartment but remains relatively amorphous in the CGCaP compartment. The layered 
scaffold contains no alignment. We hypothesize that we will see differential cellular response as 
a function of increasing strain, scaffold compartment, and scaffold type.  
 
3.2: Materials and Methods 
3.2.1 CG suspension preparation 
A CG suspension was prepared from type I collagen (1.0% w/v) isolated from bovine dermis 
(Sigma-Aldrich, St. Louis, MO) and chondroitin sulfate (0.1% w/v) derived from shark cartilage 
in 0.05 M acetic acid. The suspension was homogenized at 4 °C to prevent collagen 
gelatinization during mixing and was degassed before use. 
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3.2.2 CGCaP suspension preparation 
A CGCaP suspension was prepared from type I collagen (1.93% w/v) isolated from bovine 
dermis (Sigma-Aldrich, St. Louis, MO) and chondroitin sulfate (0.84% w/v) derived from shark 
cartilage in 0.1456M phosphoric acid / 0.037M calcium hydroxide buffer solution. The 
suspension was homogenized at 4 °C to prevent collagen gelatinization during mixing. Calcium 
salts (Ca(OH)2) and Ca(NO3)·4H2O) were added during homogenization and suspension was 
degassed before use. This suspension has previously been shown to produce 40 wt% mineral 
scaffolds by a titrant-free concurrent mapping method.150 
 
3.2.3 Layered scaffold creation 
Custom aluminum molds (0.8”x3”) with a removable, flat divider were filled with CG 
suspension (4.4 mL) in one compartment and CGCaP suspension (4.4 mL) in the other. The 
suspension-loaded mold was placed on a freeze-dryer shelf (VirTis, Gardiner, NY) at 20 °C, the 
divider was removed. The shelf temperature was then ramped down to -40 °C at a rate of 1 
°C/min and held at -40 °C for 1 hour to ensure complete freezing. Following freezing, the shelf 
temperature was ramped up to 0 °C at a rate of 1 °C/min while pulling a 200 mTorr vacuum to 
remove ice crystals via sublimation.  
 
3.2.4 Osteotendinous scaffold creation 
Osteotendinous CG-CGCaP scaffolds were fabricated via lyophilization from a 2:1 volumetric 
ratio of CG and CGCaP suspensions. Prior to lyophilization the suspension was maintained at 4 
°C to prevent gelatinization. Scaffolds were fabricated by a directional solidification step using a 
custom polytetrafluoroethylene (PTFE) and copper mold prior to sublimation to create 
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anisotropic pores within the CG compartment. The mold consisted of a PTFE block with 
cylindrical wells (6 mm diameter, 15 mm deep) extending to a 1/16” thick copper base plate. The 
CG suspension was first pipetted into the PTFE-copper mold, followed by the CGCaP 
suspension. Both suspensions were allowed to diffuse for approximately 20 minutes and were 
then placed onto a pre-cooled freeze-dryer shelf (-40 °C). The rapid solidification and significant 
thermal conductivity mismatch of the mold materials (kCU/kPTFE~1600) promotes unidirectional 
heat transfer through the copper bottom. The suspension was then held at the specified freezing 
temperature for 1 hour to ensure complete solidification, and then sublimated under vacuum (0 
°C, 200 mTorr).  
 
3.2.5 HMSC culture 
The hMSCs used in this experiment were provided by the Knight Group. The hMSCs were 
cultured in complete MSC growth medium at 37 °C and 5% CO2, fed every 3 days, and used 
before passage 6 for all experiments. Multi-compartment scaffolds (layered: 4 mm width, 4 mm 
thickness, 16 mm length; osteotendinous: 6 mm diameter, 15 mm length) were seeded using a 
previously established seeding method.38 Briefly, scaffolds were partially dried with Kimwipes 
and seeded with 6x104 MSCs in 60 µL per side (3 x 20 µL along the length of the scaffold) in 
six-well plates with 1% agarose gel for low attachment. Scaffolds were transferred to complete 
MSC media after a 30 minute attachment period. 
 
3.2.6: Multi-compartment scaffold straining 
Custom-made loading compartments and all additional tools were sterilized via autoclave. Multi-
compartment scaffolds were secured between the upper and bottom grips of a custom-made 
46 
 
loading chamber at a 10 mm gauge-length as previously described (Figure 3.1). The chamber 
was ﬁlled with complete MSC medium and sealed with a Plexiglas cylinder. Small spacers (0.4 
mm, 0.7 mm) were inserted under the upper grip to provide the desired static strain (0%, 7%, 
11%, 15%, 20%) for 16 hours at 37 °C and 5% CO2.
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3.2.7 Nuclear (Hoechst) and actin (phalloidin) staining 
Scaffolds were briefly rinsed in PBS and then transferred to formalin (Polysciences) at 4 °C 
overnight. Scaffolds were rinsed three times in PBS for 1 minute, and then incubated in 0.1% 
triton X100 for 15 minutes. Scaffolds were rinsed three times in PBS for 1 minute before being 
incubated in AlexaFluor® 555-phallodin (Invitrogen) dye methanolic stock solution (25 μL in 1 
mL PBS) for 30 minutes. Scaffolds were rinsed three times in PBS for 1 minute, and then 
transferred to a Hoechst (Invitrogen) stock (1 μL in 800 μL PBS) for 5 minutes. Scaffolds were 
rinsed three times in PBS for 1 minute, transferred to fresh PBS, and stored in the dark at 4°C 
until imaging. 
 
3.2.8 Confocal imaging 
Scaffolds were imaged within 48 hours of fixation using a Leica TCS SP2 laser scanning 
confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany). Samples were imaged at 
20X using the HeNe (excitation: 543 nm, collection: 560-700 nm) and UV (collection: 370-535 
nm, filter ND50). 
 
3.2.9 HMSC nuclear response to strain in multi-compartment scaffolds 
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HMSC nuclei images were analyzed in ImageJ using ovuscule, which has previously 
demonstrated the ability to measure the orientation and aspect ratio of elliptical shapes.160 
Ovuscule was used to fit an ellipse to the cell nucleus, which then is parameterized by three xy-
coordinates that define the ellipse function. Ovuscule returns these three xy-coordinates (x1, x2, 
x3, y1, y2, y3) along with the energy (J), the major (a) and minor (b) axis, and orientation (phi) 
of the ellipse. Nuclear aspect ratio was taken as the ellipsoidal major axis (a) divided by the 
minor (b) axis and nuclear orientation was taken to be the ellipsoidal orientation (phi). 
 
3.2.10 HMSC cytoskeletal response to strain in multi-compartment scaffolds 
Actin analysis was performed in collaboration with Stephen Thorpe (postdoctoral student, Dr. 
Martin Knight’s lab, Queen Mary University of London). Actin alignment was determined using 
a MATLAB code which determined gradients in intensity across the image to find actin fibers. 
At the location of an actin fiber, the image is split into small regions (25x25 pixels) and the actin 
orientation is measured along each angle. The dominant angle is then determined.161 
 
3.2.11 Statistics 
One-way ANOVA was performed on nuclear aspect ratio and actin aspect ratio data followed by 
Tukey post-hoc tests. V-tests were performed on nuclear orientation using the Circular Statistics 
Toolbox in MATLAB. Significance was set at p<0.05 and error is reported as standard error of 
the mean unless otherwise noted. 
 
3.3: Results 
3.3.1 HMSC nuclear aspect ratio response to varying strains in multi-compartment scaffolds 
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Both layered and osteotendinous multi-compartment scaffolds were strained to 0, 11, and 20 
percent strain. Nuclear aspect ratio in the aligned, non-mineral compartment was higher than the 
mineralized compartment in the osteotendinous scaffolds at 0 percent strain, most likely due to 
microstructural anisotropy which has been previously determined in our lab.147 However, as 
strain increased in the osteotendinous scaffolds, the nuclear aspect ratio in the mineralized 
compartment surpassed that of the non-mineralized compartment (Figure 3.2(A)). There was no 
difference found between compartments in the layered scaffolds (Figure 3.2(B)). However, 
nuclear aspect ratio in the osteotendinous scaffolds was consistently higher than in the layered 
scaffolds (p<0.05) (Figure 3.3). Most notably, at 0 percent strain, the aligned compartment also 
had the highest nuclear aspect ratio (p=0.032) (Figure 3.3(A)). At 11% strain, both mineralized 
and non-mineralized compartments of the osteotendinous scaffold display higher nuclear aspect 
ratios than the layered scaffolds (p<0.01) (Figure 3.3(B)). At 20% strain, the mineralized 
compartment of the osteotendinous scaffold displays the highest nuclear aspect ratio, with the 
non-mineralized compartment of the osteotendinous scaffold still displaying higher nuclear 
aspect ratio than the layered scaffolds (p<0.01) (Figure 3.3(C)).  
 
3.3.2 HMSC nuclear orientation response to varying strains in multi-compartment scaffolds 
Within the layered scaffolds, the only group which displayed any significant nuclear orientation 
along the direction of strain was the non-mineralized compartment at 11% strained (p=0.036) 
(Figure 3.4). It should be noted that this is a physiologically relevant level of strain. Within the 
osteotendinous scaffolds, the aligned, non-mineral compartment displayed a significant nuclear 
orientation even without strain (p=0.039). As strain increased, more alignment in both 
compartments of the osteotendinous scaffolds was found (p<0.05) (Figure 3.5). 
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3.3.3 HMSC cytoskeletal response to varying strain in multi-compartment scaffolds 
Actin alignment was analyzed in layered scaffolds and osteotendinous scaffolds (strain: 0%, 
11%, 20% strain) using the previously described MATLAB code.161 Both groups of scaffolds 
showed no differences in actin alignment with strain and showed no differences in actin 
alignment between mineral and non-mineral compartments. However, the osteotendinous 
scaffolds appeared to have more aligned actin in the direction of strain and pore alignment than 
the layered scaffolds. However, this trend was not supported by statistical analysis, which 
showed no difference between groups. This is most likely due to the limited number of samples 
we were able to obtain (Figure 3.6); ongoing efforts are expanding the sample size for these 
analyses. 
 
3.4: Conclusions and Future Directions 
Throughout this chapter we have described a method in which to strain multi-compartment 
scaffolds and measure cellular response (nuclear aspect ratio, nuclear orientation, actin 
alignment) to strain. Overall, we found that the osteotendinous scaffolds produced more of a 
cellular response. However, this response did not trend with increasing strain, which supports a 
pore architecture driven cellular response.  
 
Furthermore, this response suggests that static strain itself may not be stimulating MSCs on our 
scaffolds. Instead, static strain may be producing additional tension in the scaffold, but only 
along the struts that are aligned in the direction of applied strain. The osteotendinous scaffolds 
already contain highly aligned pores, so this effect may be more pronounced within this scaffold 
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variant. The additional tension in the scaffold may be experienced by cells as simply a substrate 
which is more difficult to deform, or a slightly “stiffer” substrate. Any cell not adhered to a strut 
which is aligned in the direction of strain may simply not experience additional “stiffness”, and 
therefore may not experience any stimuli which would elicit a cellular response. 
 
In order to determine why cellular response was not correlated with compartment or strain, but 
rather with scaffold type, further investigation into micromechanical and compartment-specific 
properties of these scaffolds is needed. Future experiments will focus on characterizing the 
biophysical microenvironment within the scaffolds. We will also explore how cyclic strain 
effects cellular response using a custom-made bioreactor, as this is a more physiologically 
relevant stimulus. We can also expand our definition of cellular response to include gene 
expression and pathway activation in the future. Finally, we are not only interested in bulk 
cellular response, but response across the interface of our multi-compartment. Future work will 
focus on how to visualize the interface in order to describe cellular response in a tight, spatially-
specific manner.  
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3.5: Figures 
 
Figure 3.1: Schematic of an individual loading chamber. Components of the loading chamber are 
labeled and the scaffold is secured between the upper and bottom grips. To secure a scaffold 
within the loading chamber, the upper grip is removed from the chamber, the 1-mm thick plate 
and the screws are removed from the upper grip, and the scaffold is placed on the ﬂat end of the 
upper grip. The 1-mm thick plate is then dropped back into place and secured with two screws, 
which are 2 mm apart. The upper grip is then inserted into the chamber, where it is prevented 
from rotating by a pin at the top of the chamber. The bottom grip is removed and the other end of 
the scaffold is placed between the two bottom screw holes. The bottom grip is then dropped back 
into place and secured with two screws. The chamber is ﬁlled with complete MSC medium and 
sealed with a Plexiglas cylinder. O-rings prevent the chamber from leaking. Small spacers (0.4 
mm, 0.7 mm) are inserted under the upper grip to provide the desired static strain.154  
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Figure 3.2: Overnight strain impacts nuclear aspect ratio. A) Osteotendinous scaffolds show an 
increase in nuclear aspect ratio in the mineralized compartment of the scaffold while the non-
mineralized compartment displays no difference. B) Layered scaffolds show no differences in 
nuclear aspect ratio with strain. 
   
A) 
B) 
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Figure 3.3: Comparison of scaffold type on nuclear aspect ratio A) At 0% strain, the non-
mineralized compartment of the osteotendinous scaffold shows the highest nuclear aspect ratio. 
It should be noted that this compartment is the only scaffold which has an aligned pore structure. 
B) At 11% strain, both mineralized and non-mineralized compartments of the osteotendinous 
scaffold display higher nuclear aspect ratios than the layered scaffolds. C) At 20% strain, the 
mineralized compartment of the osteotendinous scaffold displays the highest nuclear aspect ratio, 
with the non-mineralized compartment of the osteotendinous scaffold still displaying higher 
nuclear aspect ratio than the layered scaffolds.   
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Figure 3.4: Layered scaffold nuclear orientation. The only group which displayed any significant 
nuclear orientation along the direction of strain was the non-mineralized compartment strained to 
11%, which mimics tendon strain at physiologically relevant levels. *significantly aligned at 0 
degrees (p<0.05) 
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Figure 3.5: Osteotendinous scaffold nuclear orientation. The aligned, non-mineral compartment 
displayed a significant nuclear orientation even without strain, mostly likely due to the 
microarchitecture of the scaffold. As strain increased, more alignment in both compartments of 
the osteotendinous scaffolds was found. *significantly aligned at 0 degrees (p<0.05) 
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Figure 3.6: Actin alignment in layered and osteotendinous scaffolds after strain. The 
osteotendinous scaffolds appear to have more aligned actin fibers than the layered scaffolds. This 
apparent trend was not supported by statistics, which showed no difference. However, more 
samples are needed in order to be conclusive. Actin alignment is not a function of strain or of 
scaffold compartment. 
  
Mineral 
Non-Mineral 
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CHAPTER 4: ORTHOGONAL MANIPULATION OF BIOMOLECULAR PATTERNS 
AND BIOMECHANICS ON 2D CG SUBSTRATES
1
 
4.1: Introduction 
In the previous sections of this thesis we have limited our discussion to 3D biomaterials, which 
more closely mimic the native microenvironment cells experience in vivo. We have focused our 
discussion on the material properties of multi-compartment CG scaffolds, specifically how to 
increase their mechanical competence through interdigitation, and how to elicit a cellular 
response through mechanical stimulation and scaffold composition. However, 3D biomaterials 
are inherently complex. In this section, we will shift our focus to two-dimensional (2D) 
membranes as we examine interactions between biomolecular and biophysical cues for the sake 
of simplicity. 
 
Conventional in vitro tools often focus on presenting a single stimulating 
factor.29,97,110,111,113,114,122,162-168 However, these oversimplified materials fail to fully capture the 
complexity of cues which affect cells in vivo. Only recently have scientists begun to explore 
combinations of cues and growth factors in pursuit of synergistic effects.58,95,108,112 Additionally, 
scientists have begun to understand the enormous impact of a constellation of biomolecular and 
microenvironmental cues that make up the stem cell niche.49,169,170 A better understanding of 
these cues has set the stage for developing a new class of biomaterial which incorporates 
                                                 
 
1 This chapter has been adapted from the following publications: 
Mozdzen L.C., Banks J, Bailey R. Harley B.A (in preparation). Generating Spatially Controlled Mechanical and 
Biomolecular Cues for Instructive Collagen-GAG Biomaterials. 2014. 
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multiple environmental and biochemical cues within a single construct to elicit stem cell 
response and differentiation. 
 
There remains a need to create spatially controlled multicomponent substrates to elucidate the 
multi-parametric response of cells to their microenvironment. In this chapter, we describe an 
orthogonal photochemical immobilization technique and mechanical property manipulation of a 
CG membrane. Here, we investigate the synergistic effects of multiple biochemicals (BMP-2, 
PGDF-BB) and mechanical (elastic modulus) cues on adipose-derived stem cell (ASC) 
differentiation using spatially distinct patterns of growth factors. 
 
4.2: Materials and Methods 
All reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. 
 
4.2.1 CG Suspension Preparation 
A CG suspension was prepared from type I collagen (1.0% w/v) isolated from bovine dermis 
(Devro Inc, Columbia, SC) and chondroitin sulfate (0.1% w/v) derived from shark cartilage in 
0.05 M acetic acid. The suspension was homogenized at 4 °C to prevent collagen gelatinization 
during mixing and was degassed before use. 
 
4.2.2 Fabrication of CG membranes 
CG membranes were fabricated via an evaporative process previously described by our lab81. 
The CG suspension was degassed and pipetted into a plastic petri dish to produce a film via 
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evaporation in the fume hood. The film was then formed into 8 mm circles with a biopsy punch, 
to be used as CG membranes. 
 
4.2.3 Functionalization of CG membranes with benzophenone 
Benzophenone-4-isothiocyanate (synthesized using an established method) was dissolved 
dimethyl formamide (DMF) to a final concentration of 20mM. 0.5 M N,N-diisopropylethylamine 
was subsequently added to the solution. CG membranes were added to the benzophenone-
containing solution and allowed to react for 48 hours protected from light. Membranes were 
rinsed in DMF (three times totaling 3 hr), ethanol (1 hr), and finally phosphate buffered saline 
(PBS) pH 7.4 for storage. Membranes were stored at 5ºC and protected from light. 
 
4.2.4 Biomolecular photoattachment 
Stock solutions of bone morphogenetic protein 2 (R&D Systems, Minneapolis, MN) and platelet 
derived growth factor BB (R&D Systems, Minneapolis, MN) were prepared according to the 
manufacturer’s instructions and stored at -20 °C until use. To prepare for patterning, CG 
membranes were soaked in a solution containing 5 μg/mL of a single protein in PBS. After one 
hour, each membrane was transferred to a glass slide and 40 μL of protein solution was pipetted 
onto the top of the membrane. The membrane was covered with a coverslip and exposed to 
~20mW/cm2 of UV light using an argon ion laser (Laser Innovations, Santa Paula, CA). After 
UV exposure, the membrane was rinsed in a solution of 0.2% pluronic F-127 in PBS for 1 hour. 
To immobilize a second protein, membranes were further rinsed in PBS for 1 hour followed by 
soaking in the desired protein solution for 1 hour and subsequent irradiation. Membranes were 
stored in PBS at 5ºC before being used for cell studies. 
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4.2.5 Fluorescent visualization of biomolecular patterns 
In order to visualize biomolecule attachment, membranes containing immobilized proteins were 
transferred from 0.2% pluronic F-127 rinse buffer into a solution of 1% bovine serum albumin 
(BSA) in PBS for 1 hour. Rabbit anti-PDGF-BB antibody (AbCam, Cambridge, MA) was pre-
incubated with Alexa Fluor 647-conjugated goat anti-rabbit IgG (Invitrogen, Carlsbad, CA) in 
1% BSA-PBS. Rabbit anti-BMP-2 antibody (AbCam, Cambridge, MA) was pre-incubated with 
Alexa Fluor 647-conjugated goat anti-rabbit IgG (Invitrogen, Carlsbad, CA) in 1% BSA-PBS. 
Membranes were placed in the relevant antibody staining solutions overnight at 5ºC. After 
staining, membranes were rinsed for at least 1 hour in PBS and visualized using a fluorescence 
slide scanner (Axon Instruments-Molecular Devices, Sunnyvale, CA). 
 
4.2.6 CG membrane cross-linking 
Membranes stored in phosphate-buffered saline (PBS) were cross-linked using carbodiimide 
chemistry88,171 for 1 hour in a solution of 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride (EDC) and N-hydroxysulfosuccinimide (NHS) at a molar ratio of 1:1:5 (ratio 2), 
5:2:5 (ratio 3), 5:20.7:1 (ratio 4), 5:2:1 (ratio 5) EDC:NHS:COOH. A control group was not 
cross-linked (ratio 1). Membranes were then stored in PBS until use. 
 
4.2.7 Mechanical characterization 
Tensile mechanical tests were performed on hydrated CG membranes (10 mm gauge length x 6 
mm wide; 0.6 mm thickness,) at a rate of 1.0 mm/min using a Bose Electroforce BioDynamic 
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5110 with a 1000 g load cell. Data was collected with Bose WinTest software. The elastic 
modulus was calculated from the linear region of the stress-strain curve for each sample. 
 
4.2.8 Culture of adipose-derived mesenchymal stem cells and CG membrane seeding 
Primary adult porcine adipose-derived stem cells (ASCs) were isolated according to published 
procedures172 and stored in liquid nitrogen until use. ASCs were thawed and plated in tissue 
culture flasks containing high glucose Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum, 1% penicillin g-streptomycin and 5.0 mg/l 
amphotericin b. Cells were incubated at 37 °C with 5% CO2 and the culture medium changed 
every 3 days. Cells were rinsed with PBS and harvested using 0.25% trypsin-
ethylenediaminetetraacetic acid (EDTA) for several minutes followed by addition of an equal 
volume of complete medium. ASCs were centrifuged at 200g for 5 minutes and resuspended to a 
concentration of 1x105 cells per 20 μL. 50,000 cells in 10 μL media were seeded onto one side of 
each of the prepared CG membranes in ultra-low attachment 6-well plates (Corning Life 
Sciences, Lowell, MA) and incubated at 37 °C with 5% CO2 for 30 minutes. Membranes were 
flipped and the remaining 10 μL of cells was added to the other side of the membrane. After 30 
minutes of incubation at 37 °C to allow cell attachment, 5 mL of complete DMEM was added to 
each well. The culture medium was changed every 3 days. 
 
4.2.9 Quantifying cell attachment 
Hoechst 33258 dye (Invitrogen, Carlsbad, CA) was used to fluorescently label double-stranded 
DNA. Cells were quantified at day 0 for initial cellular attachment, and at days 1, 4 and 7 for 
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subsequent proliferation using a fluorescence spectrophotometer (Tecan Group Ltd., Männedorf, 
Switzerland) 
 
4.2.10 Characterizing cell bioactivity 
Cellular bioactivity was characterized via alamarBlue (Invitrogen DAL1100) at days 0, 1, 4, and 
7 according to the manufacturer’s instructions. Scaffolds were incubated in the alamarBlue 
solution with gentle shaking for 1 hour. Viable cells reduce the resazurin in the alamarBlue 
solution to resorufin, which produces fluorescence. Fluorescence was measured (excitation 540 
nm, emission 580 nm) on a fluorescent spectrophotometer (Tecan). 
 
4.2.11 RNA isolation, cDNA synthesis, and quantitative real time polymerase chain reaction 
Membranes were rinsed in PBS to remove unattached cells. Total RNA was isolated using the 
RNeasy plant kit (Qiagen Inc., Valencia, CA) and converted to cDNA using a QuantiTect 
reverse transcription kit (Qiagen Inc., Valencia, CA), both according to the manufacturer’s 
instructions. Alkaline phosphatase (ALP), type 1 collagen alpha-1 (COL1A1), glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), osteocalcin (OCN), and peroxisome proliferator-activated 
receptor gamma (PPARG) gene expression with three independent replicates of each 
experimental condition were analyzed by quantitative real-time polymerase chain reaction (qRT-
PCR) using primers derived from the literature or created using PrimerBLAST to conform to 
Applied Biosystems standards. qRT-PCR was performed using a 7900HT Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA). The cDNA was amplified according to the 
following conditions: 50 °C for 2 minutes and 95 °C for 10 minutes, then 95 °C for 15s and 60 
°C for 60s for 40 amplification cycles. Amplification was monitored by SYBR Green and a 
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dissociation melting curve was performed to confirm a single PCR product. Results were 
analyzed using SDS Software and the transcripts of interest were normalized to the housekeeping 
gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Relative fold change was 
calculated using the delta-delta Ct method. 
 
4.2.12 Statistics 
One-way ANOVA was performed on membrane stiffness, cellular bioactivity, and cellular 
proliferation data followed by Tukey post-hoc tests. Significance was set at p<0.05 and error is 
reported as standard error of the mean unless otherwise noted. 
 
4.3: Results 
4.3.1 Characterization of functional patterns of growth factors on CG membranes 
BMP-2 and PDGF-BB were immobilized on separate membranes, either in discrete patterns of 
stripes or squares (Figure 4.1(A-B)) or over the entire surface. Increasing exposure time to UV 
light resulted in increased immobilization of each biomolecule (Fig. 4.1(C-D).  
 
4.3.2 Mechanical properties of cross-linked CG membranes 
Cross-linking of CG membranes with varying ratios of EDC and NHS resulted in significant 
increases to the elastic moduli for ratio 3, ratio 4, and non-cross-linked membranes (Fig. 4.2).  
 
4.3.3 Orthogonal control of biomolecular patterning and CG membrane stiffness 
UV light exposure was not found to significantly affect the stiffness of the membranes (Fig. 
4.3(A)). No significant difference in biomolecular immobilization was observed using CG 
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membranes of varying cross-linking density. Together, these suggest orthogonal control of 
biomolecular patterning and CG membrane stiffness (Figure 4.3(B)). 
 
4.3.4 Cellular bioactivity, quantification, and gene expression on CG membranes patterned with 
PDGF-BB 
The biological activity of immobilized PDGF-BB (low or high immobilization) was assessed in 
membranes of increasing stiffness. We found a significant increase in metabolic activity in 
membranes patterned with PDGF-BB compared to membranes without PDGF-BB, but not in a 
dose-dependent manner (Figure 4.4(A)). This increase in bioactivity was significant for 
membranes regardless of substrate stiffness. A similar increase in cell number was also observed 
for PDGF-BB-containing membranes. The greatest increase in cell number was on moderately 
stiff membranes, suggesting an optimal stiffness for cell proliferation (Figure 4.4(B)). 
Comparatively, expression of type I collagen alpha-1 (COL1A1), alkaline phosphatase (ALP), 
and osteocalcin (OCN) gene transcripts was upregulated with increasing substrate stiffness, and 
downregulated with increasing amounts of immobilized PDGF-BB (Figure 4.5(A-C)).  
 
4.3.5 Cellular bioactivity, quantification, and gene expression on CG membranes patterned with 
BMP-2 
Immobilized BMP-2 did not influence cellular proliferation or bioactivity (Figure 4.6(A-B)). 
Cells showed an up-regulation in alkaline phosphatase strongly correlated with substrate 
stiffness, regardless of whether BMP-2 was immobilized (Figure 4.7(A). A decrease in 
peroxisome proliferator-activated receptor gamma (PPARG) gene expression was observed for 
both cross-linked membrane groups as well as all membranes containing BMP-2 (Figure 4.7(B)). 
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4.3.6 Gene expression on membranes patterned in quadrants of PDGF-BB and BMP-2 
CG membranes were patterned sequentially by immobilizing half the membrane with BMP-2, 
then rotated 90 degrees and half exposed to PDGF-BB, resulting in a single substrate with all 
possible protein combinations in 4 quadrants (BMP-2/PDGF-BB, BMP-2 only, PDGF-BB only, 
none). Expression of type I collagen increased on BMP-2 and dual patterned quadrants, while 
expression decreased on PDGF-BB and control portions of the membrane (Figure 4.8).  
 
4.4: Conclusions 
This work describes fabrication and characterization of CG membranes with independent control 
of mechanical and biochemical presentation. It has been increasingly recognized that 
mechanical, structural, and biochemical cues must all be controlled in order successfully 
investigate and instruct cell behavior. However, orchestrated control of these properties is 
challenging. Many studies have focused on controlling only one property at a time, notably IGF-
1162 and TGFβ173-175 for tendon phenotype; BMP-2 for bone phenotype97,176,177; and PDGF for 
proliferation113,178-180, leaving combinatorial effects poorly understood.  
 
Using a CG-membrane photolithography approach, we were able to investigate independent and 
combined effects of biophysical signals (stiffness) and multiple biomolecular cues (BMP-2, 
PDGF-BB). We have previously demonstrated the utility of benzophenone-based biomolecule 
immobilization on a variety of materials and surfaces. In this study, PDGF-BB and BMP-2 were 
incorporated to induce cell proliferation and osteogenesis, respectively. These two biochemical 
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cues were covalently linked to CG-membranes with precise control over spatial presentation and 
ligand density (Figure 4.1). Based on previous results, we tuned the mechanical properties of 
collagen membranes by varying the ratio of EDC and NHS cross-linking agents. We identified 
two cross-linking ratios with significantly different stiffness from each other and from non-cross-
linked control membranes (Figure 4.2). Importantly, biomolecule immobilization did not alter 
the initial mechanical properties of the membranes, and chemical cross-linking did not impact 
later surface bioconjugation (Figure 4.3). Cells were added after material fabrication to ensure no 
adverse effects from UV light exposure.  
 
After orthogonal control of biomolecule attachment and mechanical stiffness was demonstrated, 
we investigated the effect of these properties on adipose-derived mesenchymal stem cell 
bioactivity. We observed significantly increased metabolic activity and cell proliferation on 
substrates with low and high doses of immobilized PDGF-BB as compared to controls (Figure 
4.4). We also found that matrix stiffness contributed to cell proliferation, which peaked at 
intermediate substrate stiffness at the highest dose of PDGF-BB. Matrix stiffness has been shown 
to increase growth-factor-dependent Erk activation through focal adhesion assembly.181 This 
may explain the differential response to PDGF-BB-induced proliferation, in which Erk activation 
plays a major role. Facile identification of an optimal combination of PDGF-BB density and 
substrate stiffness highlights the effectiveness of our approach. Similar to our previous 
observations121, there appeared to be a tradeoff between cell proliferation and phenotype with 
PDGF-BB supplementation. While COL1A1, ALP, and OCN expression were all up-regulated 
with increasing stiffness, this effect was erased with addition of PDGF-BB (Figure 4.5). In order 
to induce osteogenic phenotype, we examined the effects of BMP-2 immobilization. As 
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expected, we found cell bioactivity was not correlated with BMP-2 regardless of stiffness (Figure 
4.6). Gene expression profiles showed that BMP-2 had little effect, suggesting that mechanical 
properties dominated cell phenotype (Figure 4.7). Bone marker ALP was up-regulated, while 
adipose marker PPARG was down-regulated with increasing stiffness. This result is not 
surprising, as stiffer substrates that more closely mimic bone are well known to elicit 
osteogenesis. 
 
Moving towards a more accurate representation of the complex microenvironment, we 
immobilized multiple biomolecular species on a single substrate with highest stiffness. No 
significant difference in metabolic activity or cell number was observed after 7 days (data not 
shown); however, expression of COL1A1 was strongly increased with the presence of BMP-2 
alone or in combination with PDGF-BB (Figure 4.8). Substrates containing PDGF-BB alone, or 
no immobilized growth factors, showed marked down-regulation of COL1A1. Although we were 
not able to observe significant increased cell proliferation, it is likely that presentation of 
proliferation and differentiation cues simultaneously in the right doses could yield an increased 
population of differentiated stem cells for use in tissue engineering applications. 
 
Overall, our results suggest that bioactivity and lineage commitment of mesenchymal stem cells 
depend on a variety of cues whose optimal combinations are difficult to predict. Systematic 
examination of such a constellation of cues requires platforms such as the one presented here. 
Ongoing development of the platform focuses on translation from 2D to 3D scaffold substrates 
and creation of immobilized biomolecular gradients to mimic graded biological interfaces.  
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This work establishes the ability to separate fabrication, biomolecule patterning, and cell 
incorporation processes by combining CG-membranes with molecularly general 
biophotolithography. We have demonstrated independent control of the immobilization of 
multiple biomolecular species as well as the mechanical properties of the substrate, allowing us 
to examine the interplay between mechanical and biochemical cues on stem cell fate. We have 
demonstrated that Benzophenone is a viable approach to covalently attach growth factors to CG 
biomaterials to elicit cellular response. This approach could prove to be a valuable tool for high 
throughput screening of stem cell niches. A faster method to better understand cellular response 
to microenvironment offers a path forward for guided tissue regeneration. 
  
69 
 
4.5: Figures 
 
Figure 4.1: Characterization of functional patterns of growth factors on CG membranes. Creation 
of immobilized growth factor patterns using a photomask and immunostained with a primary and 
fluorescent secondary antibody for (A) PDGF-BB and (B) BMP-2. Bulk growth factor 
immobilization is controlled by varying exposure time to UV irradiation for (C) PDGF-BB and 
(D) BMP-2. Control substrates were used to account for nonspecific binding. Data reported as 
mean (n=4) ± SEM 
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Figure 4.2: Mechanical properties of cross-linked CG membranes. The membranes were cross-
linked at four different EDC ratios and one control. The elastic (Young’s) modulus of the 
membranes increased with increasing cross-linking. EDC ratios 3, 4, and the control were all 
significantly different from one another (p<0.05) and were used henceforth in future 
experiments. *: significantly different elastic modulus than one another. 
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Figure 4.3: Orthogonal control of biomolecular patterning and CG membrane stiffness. A) CG 
membranes were exposed to UV irradiation and then tested mechanically. UV irradiation did not 
significantly change the mechanical stiffness of the membrane. B) CG membranes were cross-
linked at ratio 3 and ratio 4 (the ratio which produces the highest degree of cross-linking) and 
then patterned using BP-photolithographic techniques. There was no significant change in 
pattern density after cross-linking compared to non-cross-linked membranes. Data reported as 
average (n=10) ± SD. 
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Figure 4.4: Cellular bioactivity and quantification at day 7 on CG membranes patterned with 
PDGF-BB. A) At day 7, cellular bioactivity has significantly increased in membranes patterned 
with PDGF-BB compared to those not exposed to PDGF-BB. However, the response is not dose-
dependent. Both cross-linked membranes significantly increased cellular bioactivity with PDGF-
BB. B) Cell number similarly increased with patterned PDGF-BB. At the highest dosage of 
patterned PDGF-BB, there appears to be an optimal stiffness to allow an increase in cellular 
proliferation. *: significantly different from the Control/- sample.  
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Figure 4.5: Gene expression profiles of cells cultured for 7 days on CG membranes patterned 
with PDGF-BB. A) COL1A1 Expression B) ALP expression C) OCN expression increases with 
increasing stiffness, and decreases with increased PDGF-BB.   
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Figure 4.6: Cellular bioactivity and quantification at day 7 on CG membranes patterned with 
BMP-2. (A) Metabolic activity and (B) cell number at day 7 are not correlated with presence of 
BMP-2 or substrate stiffness.  
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Figure 4.7: Gene expression profiles of cells cultured for 7 days on CG membranes patterned 
with BMP-2. (A) ALP expression is upregulated as substrate stiffness increases (B) PPARG 
expression decreases as stiffness increases. 
  
76 
 
 
Figure 4.8: Gene expression profile of CG membranes patterned with PDGF-BB and BMP-2 in 2 
hemispheres, resulting in a substrate with all possible immobilization conditions in 4 quadrants 
(BMP-2/PDGF-BB, BMP-2 only, PDGF-BB only, none). Expression of type I collagen increases 
by day 7 on BMP-2 and dual patterned quadrants, while expression decreases on PDGF-BB and 
control substrates. BP=BMP-2+PDGF-BB, B=BMP-2, P=PDGF-BB, Control=no protein. 
 
  
77 
 
CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
5.1: Conclusions 
Chapter 1 first presented the motivation for creating a multi-compartment biomaterial for tendon-
bone regeneration. TBJ injuries and current techniques in surgical repair were discussed. Chapter 
1 then focused on general tissue engineering approaches to regenerate tissues, which included a 
detailed discussion of scaffold fabrication methods, biomaterial selection and functionalization. 
Finally, we presented our own approach to create multi-compartment scaffolds with spatially 
selective cues for TBJ regeneration. 
 
Chapter 2 described new methods to create interdigitated and minerally-graded multi-
compartment scaffolds. We have demonstrated the ability to localize mineral content to one 
compartment of the scaffold, have developed an analysis method to measure the width of the 
mineral gradient between compartments, and are working on controlling the width of this 
interface. We have also demonstrated the ability to create interdigitated scaffolds with increased 
mechanical competence in tension. Although we have characterized the bulk mechanical 
properties of our multi-compartment scaffolds, further work must be done to mechanically 
characterize the interface between compartments. 
 
In chapter 3, we demonstrated differential cellular response within two scaffold variants after 
strain. We saw an increase in nuclear aspect ratio, nuclear orientation, and actin alignment 
preferentially in the osteotendinous scaffolds, which contained aligned pores in the non-
mineralized compartment of the scaffold. As we did not see any significant trends in cellular 
response with strain or compartment, pore structure may be the dominant driving force in 
78 
 
cellular response. Ongoing efforts will characterize the pore structure of both scaffold variants in 
order to pursue this hypothesis.  
 
Chapter 4 established a strategy to orthogonally modulate biomolecular presentation and 
substrate stiffness. We patterned CG membranes of increasing stiffness with either PDGF-BB 
and/or BMP-2 and assessed cellular proliferation, bioactivity and gene expression to examine the 
effect of multiple biochemical and biophysical cues. We found that PDGF-BB promoted cellular 
proliferation and bioactivity, as expected, and that BMP-2 did not. There appeared to be a trade-
off between cellular proliferation and phenotype in the PDGF-BB patterned membranes. With 
increasing stiffness, we found that an osteogenic marker (OCN) was up-regulated, down-
regulated with increasing PDGF-BB. On BMP-2 patterned membranes, we saw that an 
osteogenic marker (ALP) was up-regulated with stiffness while an adipogenic marker (PPARG) 
was down-regulated with stiffness. Over the ranges tested here, we did not observe an effect with 
the addition of BMP-2, which suggests that these cellular responses were mechanically driven. 
We next immobilized multiple factors onto a single substrate with the highest stiffness in four 
quadrants (PDGF-BB only; BMP-2 only; BMP-2+PDGF-BB; No BMP-2/No PDGF-BB). 
Although we observed no difference in proliferation or bioactivity after 7 days, we did see a 
change in gene expression. In both quadrants containing BMP-2, COL1A1 was strongly up-
regulated, while both quadrants lacking BMP-2 displayed down-regulation of COL1A1.  
 
5.2: Future Work 
Additional experiments will further characterize the mechanics of these materials. Thus far, we 
have been unsuccessful in differentiating interface width between scaffold variants with 
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increasing diffusion time. However, by characterizing both the mineral content and the micro-
mechanical properties, we may be able to elicit these differences by using this data collectively. 
Although we have shown increasing mechanical competence with increasing interdigitation, we 
are far from an optimal geometry across the interface. We will further modulate the interfacial 
geometry in order to minimize stress concentrations. We will look at digital image correlation 
and modeling techniques to characterize local mechanics of the scaffold. We are also in the 
process of characterizing the pore structure of both scaffolds variants across both compartments 
as well as the interface. Finally, instead of incorporating 2 compartments into a single scaffold, it 
may be advantageous to incorporate 3 compartments, one for each the tendon, bone, and junction 
tissues. We have recently begun using a 3D printer to create molds and dividers, which can 
provide much more flexibility in the types of scaffolds we can create. 
 
In addition to mechanical properties, we will further explore stem cell response within the 
scaffold as well. We have described changes in stem cell phenotype with static strain, although 
these responses appeared to be related to scaffold pore architecture. Next, we will use a custom-
made bioreactor to provide cyclic strain to these scaffolds. Finally, we can further characterize 
cellular response by looking at gene expression and pathway activation. 
 
Most of the work described in this thesis focused on bulk characterization in a single 
compartment of the scaffold. Although this information is integral to understanding how stem 
cells respond in a multi-compartment scaffold, we would also like to examine the interstitial 
zone between the two compartments. In order to do this, we will need to be able to readily 
visualize the interface. As we increase the width of this interface, we would like to examine 
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cellular behavior more closely. One question we are pursuing is whether cells behave 
fundamentally different when the width of the interface is on the same order of magnitude as the 
cell, or whether there remains a gradation in cellular behavior. We hypothesize that a mineral 
content gradient will elicit a cellular response similar to that found at the TBJ. 
 
The overall goal of this work is to eventually incorporate the techniques described in this thesis 
into a single 3D CG construct to promote TBJ regeneration.  
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APPENDIX A: PROTOCOLS 
A.1: CG Suspension Preparation Protocol 
Reference: Yannas, Lee et al. 1989; O'Brien, Harley et al. 2004; Caliari and Harley 2011; 
Gonnerman, McGregor et al. in preparation  
 
Reagents  
• Collagen from bovine Achilles tendon (Sigma-Aldrich C9879); store at 4ºC  
• Chondroitin sulfate sodium salt from shark cartilage (Sigma-Aldrich C4384); store at 4 
°C  
• Glacial acetic acid (Sigma-Aldrich 71251)  
• Ethylene glycol (VWR BDH1125-4LP)  
• Deionized water  
 
Equipment and Supplies  
• Recirculating chiller (Fisher Isotemp Model 900)  
• Rotor-stator (IKA 0593400)  
• Disperser S-25N-18G (IKA 0593400) 
• Disperser S-25N-25G-ST (IKA 4447500) 
• 250 mL Jacketed beaker  
• Freeze-dryer (VirTis Genesis)  
• Beakers  
• Parafilm  
• Spatula 
• Tweezers 
 
Procedure 
 
*This procedure describes how to make 200 mL (maximum batch size) of 0.5% CG suspension. 
Scale collagen and glycosaminoglycan (GAG) content appropriately to create different volumes 
of suspension.  
 
1. Fill recirculating chiller with a 50/50 mix of ethylene glycol and deionized water, making 
sure that the cooling coils are completely immersed in the liquid. Set the recirculating 
chiller to 4 °C. 
2. Attach recirculating chiller to 250 mL jacketed beaker so that the coolant enters at the 
jacketed beaker’s base and exits at the beaker’s top. Allow for the temperature to 
equilibrate to 4 °C, about 30 minutes. Maintaining this temperature is important, as it will 
prevent the collagen from denaturing during the blending process.  
3. Prepare a 0.05 M solution of acetic acid by adding 0.58 mL of glacial acetic acid to 200 
mL of deionized water.  
4. Weigh 1.0 g of collagen and add to the jacketed beaker.  
5. Pour 170 mL of the 0.05 M acetic acid into the jacketed beaker. 
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6. Assemble the rotor-stator and S-25N-25G-ST disperser (check diagrams for correct 
configuration of disperser). The disperser should be hand tight and not over torqued. 
Attach the disperser to the rotor-stator and verify the disperser is seated correctly by 
checking the line at the top of the disperser element prior to securing. Lower the rotor-
stator into the suspension. The rotor-stator should be vertical and off-center in the beaker. 
7. Blend the suspension at 12,000 rpm maximum until blended (approximately 30 min) at 4 
°C. The blender should always be started with the rpm at the lowest possible setting and 
then slowly ramped up. If abnormal noises such as grinding occur the blender should be 
slowed all the way down and turned off before the dispersing element is taken apart and 
inspected. The height of the rotor-stator may need to be adjusted via the platform during 
the blending process: If the rotor-stator is positioned too high, the holes on its side will be 
visible; if it is too low, the suspension will bubble excessively. Periodically check to see 
if the rotor-stator is clogged with collagen; remove clogs with a spatula or tweezers as 
needed. The blender should be operated with constant supervision. 
8. Remove the S-25N-25G-ST disperser and replace with S-25N-18G (check diagrams for 
correct configuration of disperser). The disperser should be hand tight and not over 
torqued. Attach the disperser to the rotor-stator and verify the disperser is seated correctly 
by checking the line at the top of the disperser element prior to securing.  
9. Add 30 mL of 0.05 M acetic acid to a 50 mL centrifuge tube. Weigh out 0.0887 g of 
chondroitin sulfate (GAG) and add to the centrifuge tube. Vortex until the GAG is fully 
dissolved. Let the GAG solution rest in the refrigerator (4 °C) for at least 10 minutes.  
10. Add the GAG solution drop-wise to the collagen suspension while it is being mixed at 
12,000 rpm maximum at 4 °C. Periodically manually stir in any GAG that remains on the 
surface of the suspension using a spatula. It may be necessary to stop and unclog the 
rotor-stator with a spatula during this process.  
11. Once all of the GAG solution has been added, blend at 12,000 rpm maximum at 4 °C 
until blended (approx. 30 min?). Periodically check to ensure the rotor-stator is lowered 
to the correct depth, as the suspension will gradually become less viscous and creep up 
the sides of the jacketed beaker. Adjust platform height as needed. Periodically check to 
see if the rotor-stator is clogged; remove clogs with a spatula or tweezers as needed.  
12. Store the suspension for at least 18-22 hours at 4 °C.  
13. Degas the suspension to remove any air bubbles prior to use. It is recommended to degas 
approximately 20 mL at a time, until the solution starts to boil. To minimize suspension 
loss during the degassing process, cover the beaker with slit Parafilm. 
14. Store the suspension at 4 °C. Periodically check the CG suspension; if not homogenous, 
re-blend at 12,000 rpm for at least 30 min at 4 °C. 
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A.2: CGCaP Suspension Preparation 
Reference: (Harley, Lynn et al. 2010; Lynn, Best et al. 2010), Process Record No. PR OM-004 
Preparation of Mineralized Slurry, BioUetikon and OrthoMimetics, Process Record No. PR OM-
001 Preparation of 0.1456M Phosphoric Acid/0.037M Calcium Hydroxide, BioUetikon and 
OrthoMimetics.  
 
Reagents  
• Collagen from bovine Achilles tendon (Sigma-Aldrich C9879); store at 4 °C  
• Chondroitin sulfate sodium salt from shark cartilage (Sigma-Aldrich C4384); store at 4 
°C  
• 0.1456M phosphoric acid / 0.037M calcium hydroxide buffer solution  
o 5.904 mL 85% phosphoric acid (Sigma-Aldrich P5811)  
o 570 mL deionized water  
o 1.644 g calcium hydroxide (Sigma-Aldrich 31219)  
o Add acid to water, then calcium hydroxide. Bring volume to 600 mL and adjust 
pH to 2.0-2.4. Solution is good for 3 months.  
• Calcium hydroxide (Sigma-Aldrich, 31219)  
• Calcium Nitrate Tetrahydrate (Sigma-Aldrich, 31218)  
• Ethylene glycol (VWR BDH1125-4LP)  
• Deionized water  
 
Supplies and equipment  
• Recirculating chiller (Fisher Isotemp Model 900)  
• Rotor-stator (IKA 0593400)  
• Disperser S-25N-18G (IKA 0593400) 
• Disperser S-25N-25G-ST (IKA 4447500) 
• 250 mL Jacketed beaker  
• Freeze-dryer (VirTis Genesis)  
• pH meter 
• Beakers  
• Transfer pipets 
• Centrifuge tubes 
• Parafilm  
• Spatula 
• Tweezers 
  
 
Procedure  
 
*This procedure describes how to make 200 mL of 40 wt% CGCaP suspension. Scale collagen 
and GAG content appropriately to create different volumes of suspension.  
 
1. Setup the jacketed vessel, setting the water temperature to 4 °C.  
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2. Add 3.8644 g collagen to the jacketed vessel. Then add 161.41 mL of phosphate acid / 
calcium hydroxide buffer to the collagen. Assemble the rotor-stator and S-25N-25G-ST 
disperser (check diagrams for correct configuration of disperser). The disperser should be 
hand tight and not over torqued. Attach the disperser to the rotor-stator and verify the 
disperser is seated correctly by checking the line at the top of the disperser element prior 
to securing. Lower the rotor-stator into the suspension. The rotor-stator should be vertical 
and off-center in the beaker. 
3. Blend the suspension at 12,000 rpm maximum until blended (approximately 30 min) at 4 
°C. The blender should always be started with the rpm at the lowest possible setting and 
then slowly ramped up. If abnormal noises such as grinding occur the blender should be 
slowed all the way down and turned off before the dispersing element is taken apart and 
inspected. The height of the rotor-stator may need to be adjusted via the platform during 
the blending process: If the rotor-stator is positioned too high, the holes on its side will be 
visible; if it is too low, the suspension will bubble excessively. Periodically check to see 
if the rotor-stator is clogged with collagen; remove clogs with a spatula or tweezers as 
needed. The blender should be operated with constant supervision.  
4. Allow the collagen to hydrate for 18-22 hours in the cooled jacketed vessel at 4 °C. This 
mixture will become very viscous and difficult to blend. Remove the S-25N-25G-ST 
disperser 
5. Measure out 1.677 g of chondroitin sulfate and add it to 28.63 mL of phosphate acid / 
calcium hydroxide buffer in a beaker. Then mix the buffer and the chondroitin (GAG 
solution), using a magnetic stirring bar, until fully dissolved.  
6. Measure out 1.28 g calcium hydroxide and 0.78 g calcium nitrate tetrahydrate and place 
both in a 50 mL centrifuge tube. Add 10 mL of deionized water to the tube using a 
pipette. Then mix (vortex/shake) the solution to suspend the salts in the water.  
7. Set-up the rotator stator and the S-25N-18G disperser (check diagrams for correct 
configuration of disperser). The disperser should be hand tight and not over torqued. 
Attach the disperser to the rotor-stator and verify the disperser is seated correctly by 
checking the line at the top of the disperser element prior to securing.  
8. Set the blender to 12,000 rpm and blend the hydrated collagen made in step 3 until fully 
blended.  
9. Add the GAG solution prepared in step 5 to the hydrated collagen solution prepared in 
step 3 drop wise while mixing at 12,000 rpm, stirring with a spatula often to prevent any 
clumping of the collagen/GAG. With the additional volume, the slurry will mix better.  
10. Blend this GAG / hydrated collagen solution at 12,000 rpm until fully blended 
(approximately 30 minutes). 
11. Blend the collagen / GAG mixture at 200-800 rpm while adding the salts to maximize 
dispersion. Using a pipette, add the salt solution at a rate of 5mL/min to the collagen / 
GAG mixture, allowing time for blending after each volume. Then blend the slurry at 
12,000 rpm until fully blended.  
12. Stores the slurry for 18-22 hours at 2-8 °C before use. Periodically check the CG 
suspension; if not homogenous, re-blend at 12,000 rpm until well blended (approximately 
30 minutes) at 4 °C. 
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A.3: CG Membrane Preparation 
Reference: (Caliari, Ramirez et al. 2011)  
 
Reagents  
• CG suspension; store at 4 °C  
 
Supplies and equipment  
• Chemical fume hood (Lab Fabricators Company)  
• Freeze-dryer (VirTis Genesis)  
• Petri dishes (100 mm diameter)  
• Beakers  
• Parafilm  
• Kimwipes  
 
Procedure  
 
*This procedure describes how to make 1x volume membranes. Scale suspension volume and solids 
content to adjust final membrane thickness.  
 
1. Degas CG suspension in Parafilm-covered beaker by pulling vacuum inside freeze-dryer to 
remove all air bubbles. Make sure the condenser is at least -50 °C or cooler before degassing.  
2. Carefully pipette 25 mL of degassed suspension inside Petri dish. Wipe inside of Petri dish 
with Kimwipe before adding suspension to facilitate membrane removal from dish.  
3. Leave open Petri dish to dry in chemical fume hood for 1-2 days. Cover Petri dish once the 
membrane is dry and store at room temperature until use. 
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A.4: Layered Scaffold Preparation 
Reference: (Martin, Caliari, et al. 2011; Gonnerman, McGregor, et al. in preparation)(O'Brien, 
Harley et al. 2004)  
 
Reagents  
• CG suspension; store at 4 °C  
• Welch DirecTorr Gold synthetic pump oil (Fisher 01-184-105)  
 
Supplies and equipment  
• Freeze-dryer (VirTis Genesis)  
• Aluminum tray molds (3” x 3” or 1”x3”)  
• Aluminum mold dividers 
• Beakers  
• Parafilm  
• Aluminum foil  
 
Procedure  
 
*This procedure describes the fabrication of 3 mm tall scaffold sheets. Check that oil is clean 
(clear, not yellowed) before and after each freeze-dryer run, replacing when necessary. It is 
easiest to replace the oil just after a run, when the oil is still warm.  
 
1. Degas the CG suspension in a beaker (covered in Parafilm with small slits) by pulling 
vacuum inside freeze-dryer. Degas just to the boiling point to remove all air bubbles. 
Make sure the condenser is at least -50 °C or cooler before degassing.  
2. Add 24.25 mL of CG suspension to a 3” x 3” tray mold, ensuring that the suspension 
reaches the corners. Push any bubbles or unblended collagen to the edge using tweezers.  
3. Open freeze- dryer door, place mold on center of shelf. Quickly close the freeze-dryer 
door and run the program ‘Tf-xx No Hold’ where xx is the desired freezing temperature 
(-10, -40, or -60 °C). A typical schedule is shown below for the constant cooling 
fabrication method with a final freezing temperature of -10 °C. 
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PCM refers to the minimum reading difference between the Pirani and capacitance manometer 
pressure gauges that must be achieved before the program proceeds to the next step. In Pirani 
gauges, a filament in the gauge is heated so that it is at a constant temperature at a given 
pressure. As the pressure increases or decreases, the amount of gas molecule collisions with the 
filament will change accordingly. More collisions remove more heat from the filament, which 
lowers the temperature and changes the resistance of the filament. This change in resistance is 
converted to an output pressure. Pirani gauges are accurate to within around 7-8%. Capacitance 
manometers operate on the principle of a diaphragm held at a very low reference pressure (10-7 
mbar) that is deflected by changing pressure. This deflection changes the capacitance between 
the diaphragm and an electrode. This change is converted to pressure. These gauges are 
extremely accurate (1%). These gauges will read different pressures because they operate on 
very different principles. The capacitance manometer is more accurate because it reads pressure 
independent of the type of gas present. In contrast, the temperature of the filament in the Pirani 
gauge is affected by the thermal conductivity of the colliding gas molecules. For example, the 
thermal conductivity of water vapor is higher than that of air, so for an equal number of water 
vapor and air molecules colliding with the filament the water vapor will remove more heat, 
causing the Pirani gauge to read a higher pressure than the true pressure. Once all of the water 
vapor is removed the differential between the two gauges should read about the same, indicating 
that the scaffolds are dry.  
 
4. Once the program has reached the storage hold stage, the program can be cancelled and 
the array can be removed from the freeze-dryer.  
5. Gently remove scaffold by lifting from corner with tweezers. Place scaffold in puffed 
aluminum pouch. Label pouch with name, collagen type, collagen concentration, freeze 
date, freeze temperature, and any other relevant notes. Clean mold by rubbing with soapy 
water; use 0.05 M acetic acid to remove collagen residue. Do not use cleaning brushes. 
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A.5: Osteotendinous Scaffold Preparation 
Reference: (Caliari and Harley 2011; Caliari, Ramirez et al. 2011)  
 
Reagents  
• CG suspension; store at 4 °C  
• CGCaP suspension; store at 4 °C 
• Welch DirecTorr Gold synthetic pump oil (Fisher 01-184-105)  
 
Supplies and equipment  
• Freeze-dryer (VirTis Genesis)  
• PTFE-copper freeze-drying mold  
• Beakers  
• Parafilm  
• Aluminum foil  
 
Procedure 
  
*This procedure describes the fabrication of 15 mm tall aligned multi-compartment scaffolds. 
Check that oil is clean (not yellow) before and after each freeze-dryer run, replacing when 
necessary.  
 
1. Degas CG and CGCaP suspension in Parafilm-covered beaker by pulling vacuum inside 
freeze-dryer to remove all air bubbles. Make sure the condenser is at least -50 °C or 
cooler before degassing.  
2. Begin to cool freeze-dryer shelves by running 'Tf = xx C shelf cool' program, where xx is 
the desired freezing temperature (-10, -40, or -60 °C). 
3. If making scaffold-membrane composites, cut membranes to size, roll, and place in 
PTFE-copper freeze-drying mold holes.  
4. Pipette a total of 540 µL (6 mm diameter holes) of suspension into each hole in PTFE-
copper freeze-drying mold. Carefully pipet the first suspension (e.g. CG suspension, 360 
μL) into mold wells. Then, add the second suspension (e.g. CGCaP suspension, 180 μL) 
carefully on top of the first suspension, taking care not to mix the two layers. Following 
pipetting, place entire mold on Kimwipe and allow to interdiffuse for 15-30 min at 4 °C.  
5. Cancel shelf cool program and place freeze-dryer mold on the pre-cooled shelf. Shut the 
freeze-dryer door and run program 'Aligned Tf = xx' where xx is the desired freezing 
temperature (-10, -40, or -60 °C). A typical freeze-drying schedule is shown for the 
fabrication of an aligned -60°C scaffold: 
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PCM refers to the minimum reading difference between the Pirani and capacitance manometer 
pressure gauges that must be achieved before the program proceeds to the next step. In Pirani 
gauges, a filament in the gauge is heated so that it is at a constant temperature at a given 
pressure. As the pressure increases or decreases, the amount of gas molecule collisions with the 
filament will change accordingly. More collisions remove more heat from the filament, which 
lowers the temperature and changes the resistance of the filament. This change in resistance is 
converted to an output pressure. Pirani gauges are accurate to within around 7-8%. Capacitance 
manometers operate on the principle of a diaphragm held at a very low reference pressure (10-7 
mbar) that is deflected by changing pressure. This deflection changes the capacitance between 
the diaphragm and an electrode. This change is converted to pressure. These gauges are 
extremely accurate (1%). These gauges will read different pressures because they operate on 
very different principles. The capacitance manometer is more accurate because it reads pressure 
independent of the type of gas present. In contrast, the temperature of the filament in the Pirani 
gauge is affected by the thermal conductivity of the colliding gas molecules. For example, the 
thermal conductivity of water vapor is higher than that of air, so for an equal number of water 
vapor and air molecules colliding with the filament the water vapor will remove more heat, 
causing the Pirani gauge to read a higher pressure than the true pressure. Once all of the water 
vapor is removed the differential between the two gauges should read about the same, indicating 
that the scaffolds are dry.  
 
6. Once the program has reached the storage hold stage, the program can be cancelled and 
scaffolds can be removed from the freeze-dryer.  
7. Allow scaffolds to sit in mold at room temperature for at least 1 hour before carefully 
removing them with forceps and placing in an aluminum foil pouch. Label pouch with 
name, collagen type, collagen concentration, freeze date, freeze temperature, and any 
other relevant notes. 
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A.6: EDC Cross-linking Protocol 
Reference: (Olde Damink, Dijkstra et al. 1996; Harley, Leung et al. 2007; Caliari, Ramirez et al. 
2011) 
 
Reagents  
• 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC, Sigma-Aldrich 
E7750); store at -20 °C  
• N-hydroxysulfosuccinimide (NHS, Sigma-Aldrich H7377); store in desiccator  
• Sterile phosphate-buffered saline (PBS)  
• Sterile water  
• 100% ethanol  
 
Supplies and equipment  
• 6-well plates (Fisher 08-772-1B)  
• 50 mL centrifuge tubes (Fisher 14-432-22)  
• Syringe and syringe filter (Fisher 148232A)  
• MTS 2/4 digital microtiter shaker (IKA 3208001)  
• Dual range balance (Mettler Toledo XS105)  
• Razor blades  
• Biopsy punch (Fisher 12-460-413) 
 
Procedure  
 
* Note: all steps should be performed in the laminar flow hood unless otherwise noted.  
 
1. Cut scaffold samples to be cross-linked to desired sample size using a razor blade or 
biopsy punch. 
2. Transfer scaffold pieces to sterile centrifuge tube, remove from laminar flow hood, and 
weigh pieces on dual range balance.  
3. Hydrate scaffolds in 100% ethanol overnight.  
4. Rinse scaffolds several times in PBS and then let soak in PBS for 24 hours before cross-
linking. 
5. Determine the EDC and NHS concentrations to be used in cross-linking solution. The 
sample calculations in this protocol are done with a 5:2:1 EDC:NHS:COOH molar ratio 
where COOH is carboxylic acid groups in CG material based on a conversion factor of 
1.2 mmol COOH per gram of collagen (Olde Damink, Dijkstra et al. 1996). The mass of 
EDC and NHS required can be calculated as follows:  
  =   0.0012   !"#$%%&'()* +,-./  !	 /0/.1",-./,-. 	           (Equation A.1) 
 23 =   0.0012   !"#$%%&'()*  
4!5/  !	 /0/.1"4!5/4!5 	           (Equation A.2) 
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6. Mix the EDC and NHS in sterile water. Approximately 1 mL of solution will be needed 
per scaffold (6-8 mm diameter, 3-5 mm thick) 
7. In the laminar flow hood, sterile filter the solution and add to 6-well plates such that each 
scaffold is exposed to an equal amount of the EDC solution.  
8. Add scaffolds in cross-linking solution and place well plate on digital microtiter shaker in 
incubator at 37 °C. Allow scaffolds to cross-link under moderate shaking for 30-120 min. 
Cross-linking time should be increased for less permeable constructs such as membranes 
and high solids content scaffolds.  
9. Remove EDC/NHS solution and rinse scaffolds in sterile PBS under moderate shaking 
for 10-15 min.  
10. Remove first PBS wash solution and rinse scaffolds in fresh PBS under moderate shaking 
for an additional 30-45 min. Store in fresh sterile PBS until use. 
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A.7: Scaffold Glycolmethacrylate Embedding Protocol  
Reference: (O'Brien, Harley et al. 2004; O'Brien, Harley et al. 2005; Caliari and Harley 2011)  
 
Reagents  
• JB-4 embedding solution A (100 mL); store at 4 °C for up to 1 week  
o 100 mL JB-4 embedding solution A (monomer) (Polysciences 0226A-800)  
o 1.25 g JB-4 catalyst (benzoyl peroxide, plasticized) (Polysciences 02618-12);  
• JB-4 embedding solution B (accelerator) (Polysciences 0226B-30)  
• 100% ethanol  
 
Supplies and equipment  
• Polyethylene molding cup trays (Polysciences 16643A-1)  
• JB-4 plastic block holders (Polysciences 15899-50)  
• DryFast vacuum pump (Welch Vacuum 2014B-01)  
• Pyrex desiccator (Fisher 08-626B)  
• Serological pipettes (Fisher 13-678-14B)  
• 6-well plates (08-772-1B)  
• Chemical fume hood (Lab Fabricators Company)  
• Razor blades  
 
Procedure  
 
1. Cut scaffold pieces to be analyzed using a razor blade. 15 mm aligned scaffolds are 
typically cut in thirds. Both transverse and longitudinal sections should be cut for 
analysis.  
2. Place samples in 6-well plates and hydrate in 100% ethanol under vacuum inside 
desiccator for 24 hours.  
3. Add hydrated samples to JB-4 embedding solution A (see reagent list for instructions to 
make solution A) under vacuum inside desiccator at 4 °C. After 24 hours, replace with 
fresh JB-4 embedding solution A and hold under vacuum inside desiccator at 4 °C for an 
additional 48 hours.  
4. Mix 25 mL of JB-4 embedding solution A with 1 mL of JB-4 B solution and pipette ~3.5 
mL into each well of the plastic embedding mold.  
5. Place each sample into a well. The JB-4 mixture will polymerize quickly (~30 min) so 
make sure the samples stay in the proper orientation.  
6. Place one labeled plastic stub in each well once the JB-4 mixture has become sufficiently 
viscous that the stubs don't completely sink.  
7. Keep embedding mold at 4 °C overnight to allow polymerization to complete. Store 
samples at 4 °C until use. 
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A.8: Scaffold Pore Size Analysis: Aniline Blue Staining, Image Acquisition, and Linear 
Intercept Analysis Protocol  
Reference: (O'Brien, Harley et al. 2004; O'Brien, Harley et al. 2005; Caliari and Harley 2011)  
 
Reagents  
• Aniline blue solution (100 mL)  
o 2.5 g aniline blue (Fisher AC40118-0250)  
o 2 mL glacial acetic acid (Sigma-Aldrich 71251)  
o 100 mL deionized water  
o Mix well, filter before use  
• 1% Acetic acid (100 mL)  
o 1 mL glacial acetic acid (Sigma-Aldrich 71251)  
o 99 mL deionized water  
• Permount mounting medium (Fisher SP15-100)  
• 95%, 100% ethanol  
 
Supplies and equipment  
• Optical microscope with camera (Leica Microsystems DMIL LED with DFC295 camera)  
• Scion Image analysis software (Scion Co)  
• Beakers  
• Cover slips  
 
Aniline blue staining procedure  
 
1. Obtain slides of serially sectioned embedded scaffolds from histologist.  
2. Dip slides in aniline blue solution for 2-4 min. Analyze in groups of 12-18 slides.  
3. Place slides in 1% acetic acid for 1 min.  
4. Dip each slide several times in 95% ethanol until most of background staining goes away.  
5. Dip each slide several times in 100% ethanol to complete rinse and allow slides to dry.  
6. Mount each sample with 1 drop of Permount per slide section. Firmly press cover slip 
onto slide so as not to introduce any air bubbles. Allow slides to dry for 24 hours before 
further analysis.  
 
Image acquisition procedure  
 
1. Visualize embedded, sectioned, and stained scaffold samples using optical microscope.  
2. Acquire three tiff images for each transverse section and two images for each smaller 
longitudinal section using camera.  
 
Linear intercept analysis procedure  
 
1. Transfer images for analysis to a folder with a short path length from C.  
2. Open Scion Image. Under 'Special' menu select 'Load macros' and open the 'pore 
characterization macros Steven' file.  
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3. Open tiff file in Scion Image. Under 'Edit' menu, select 'Invert,' then under 'Options' 
menu select 'Threshold.' Adjust the threshold values to optimize the visualization of the 
scaffold strut network. Any extraneous spots can be cleaned with eraser tool although no 
artifacts under 5 pixels will be detected by the pore analysis macro.  
4. Under the 'Process' menu select 'Make Binary' under 'Binary' sub-menu. Save the edited 
tiff file.  
5. Under the 'Analysis' menu select 'Set Scale.' For images taken at 4x magnification the 
correct scale is 347 pixels per mm. At 10x magnification the scale is 867 pixels per mm.  
6. Select an area of the image to be analyzed with the oval drawing tool. Try to select as 
much of the viable image as possible.  
7. Under the 'Special' menu, run the 'Linear Intercept' macro. The distance between the pore 
walls along lines at five degree angle increments from the center of the selected region 
are calculated. Next, run the 'Plot Intercepts' macro. This macro transforms the average 
distance between struts to a best-fit ellipse and calculates linear intercept coefficients C0, 
C1, and C2 for the ellipse.  
8. Transfer C0, C1, and C2 data to spreadsheet to calculate minor (a) and major (b) axes of 
best-fit ellipse using the following equations: 
 6 =  /789:;<9<<       (Equation A.3) 
 
= =  > :;<9<<8:;<9<<9<<?;<      (Equation A.4) 
 @ABCD E6DFG =  H       (Equation A.5) 
 
 
9. Calculate the mean pore size (d) from values of the major and minor axes of the best-fit 
ellipse. To account for the fact that pores were not sectioned through their maximal cross-
section the mean pore size is corrected by a factor of 1.5. To convert the pore radius to 
diameter the mean pore size is additionally multiplied by 2 for a total correction factor of 
3:  
 I = 3 :<9H<
         (Equation A.6) 
 
Linear intercept macro code  
 
macro 'Linear Draw'  
{{{This macro is used for testing different line drawing routines for use  
with the macro 'Linear Intercept'}}}  
var  
left,top,width,height,MinDim,nx,ny,i,j,k:integer;  
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ThetaStep,NSteps,PI,x1,x2,y1,y2,dy,dx:real;  
Theta,valx,valy,plength,scale,AspectRatio:real;  
IntLength,LineSum:real;  
Intercepts:integer;  
switch,indicator:boolean;  
unit:string;  
begin  
GetRoi(left,top,width,height);  
if width=0 then begin  
PutMessage('Selection required.');  
exit;  
end;  
if width<height then MinDim:=width  
else MinDim:=height;  
PI:=3.141592654;  
GetScale(scale,unit,AspectRatio);  
NSteps:=GetNumber('Enter theta steps between 0 and 90 deg.',3,0);  
ThetaStep:=PI/(2*NSteps);  
for j:=0 to 2*NSteps-1 do begin  
x1:=left;  
y1:=top;  
Theta:=j*ThetaStep;  
nx:=5*sin(Theta)*width/height;  
ny:=5*abs(cos(Theta));  
for i:=0 to nx do begin  
if Theta=0 then begin  
x1:=left;  
x2:=x1+width;  
end else begin  
x1:=left+(width*i/(nx+1))+width/(2*(nx+1));  
x2:=x1+(height*cos(Theta)/sin(Theta));  
end;  
y2:=top+height;  
if x2>=left+width then begin  
x2:=left+width;  
y2:=y1+(x2-x1)*sin(Theta)/cos(Theta); 
end else if x2<left then begin  
x2:=left;  
if Theta>PI/2 then y2:=y1+(x2-x1)*sin(Theta)/cos(Theta);  
end;  
{{{plength is the length of the line to be drawn in pixels}}}  
plength:=sqrt(sqr(x2-x1)+sqr((y2-y1)/AspectRatio));  
valx:=x1;  
valy:=y1;  
dx:=(x2-x1)/plength;  
dy:=(y2-y1)/plength;  
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switch:=true;  
if plength>=MinDim then begin  
for k:=0 to plength do  
PutPixel(x1+k*dx,y1+k*dy,255);  
end;  
end;  
for i:=1 to ny do begin  
if Theta<=PI/2 then begin  
x1:=left;  
x2:=left+width  
end else begin  
x1:=left+width;  
x2:=left;  
end;  
y1:=top+height*i/(ny+1);  
y2:=y1+(width*sin(Theta)/abs(cos(Theta)));  
if y2>top+height then begin  
y2:=top+height;  
x2:=x1+((y2-y1)*cos(Theta)/sin(Theta));  
end;  
{{{plength is the length of the line to be drawn in pixels}}}  
plength:=sqrt(sqr(x2-x1)+sqr((y2-y1)/AspectRatio));  
valx:=x1;  
valy:=y1;  
dx:=(x2-x1)/plength;  
dy:=(y2-y1)/plength;  
switch:=true;  
if plength>=MinDim then begin  
for k:=0 to plength do  
PutPixel(x1+k*dx,y1+k*dy,255);  
end; {{{if}}}  
end;{{{i}}}  
end; {{{j}}}  
end;  
macro 'Linear Intercept'  
{{{This macro measures the linear intercept distance over a giver ROI  
at intervals of angle}}}  
var  
left,top,width,height,MinDim,nx,ny,i,j,k:integer;  
ThetaStep,NSteps,PI,x1,x2,y1,y2,dy,dx:real;  
Theta,valx,valy,plength,scale,AspectRatio:real;  
IntLength,LineSum,dummy:real;  
Intercepts:integer;  
switch,indicator:boolean;  
unit:string;  
begin  
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SetOptions('User1;User2');  
GetRoi(left,top,width,height);  
if width=0 then begin  
PutMessage('Selection required.');  
exit;  
end;  
if width<height then MinDim:=width  
else MinDim:=height;  
PI:=3.141592654;  
GetScale(scale,unit,AspectRatio);  
NSteps:=18;{{{GetNumber('Enter # steps between 0 and 90 deg.',3,0);}}}  
ThetaStep:=PI/(2*NSteps);  
{{{block out next line when doing cumulative measurements}}}  
SetCounter(2*NSteps);  
SetUser1Label('Theta(rad)');  
SetUser2Label('Lx10^3');  
for j:=0 to 2*NSteps-1 do begin  
LineSum:=0;  
Intercepts:=0;  
x1:=left;  
y1:=top;  
Theta:=j*ThetaStep;  
nx:=10*sin(Theta)*width/height;  
ny:=10*abs(cos(Theta));  
for i:=0 to nx do begin  
if Theta=0 then begin  
x1:=left;  
x2:=x1+width;  
end else begin  
x1:=left+(width*i/(nx+1))+width/(2*(nx+1));  
x2:=x1+(height*cos(Theta)/sin(Theta));  
end;  
y2:=top+height;  
if x2>=left+width then begin  
x2:=left+width;  
y2:=y1+(x2-x1)*sin(Theta)/cos(Theta);  
end else if x2<left then begin  
x2:=left;  
if Theta>PI/2 then y2:=y1+(x2-x1)*sin(Theta)/cos(Theta);  
end;  
{{{plength is the length of the line to be drawn in pixels}}}  
plength:=sqrt(sqr(x2-x1)+sqr((y2-y1)/AspectRatio));  
valx:=x1;  
valy:=y1;  
dx:=(x2-x1)/plength;  
dy:=(y2-y1)/plength;  
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switch:=true;  
if plength>=MinDim then begin  
LineSum:=LineSum+(plength/scale);  
for k:=0 to plength do begin  
if GetPixel(x1+k*dx,y1+k*dy)>0  
then indicator:=true  
else indicator:=false;  
if (switch=true) and (indicator=true) then begin  
Intercepts:=Intercepts+1;  
switch:=false;  
end;  
if (indicator=false) then switch:=true;  
end;  
end;  
end;  
for i:=1 to ny do begin  
if Theta<=PI/2 then begin  
x1:=left;  
x2:=left+width  
end else begin  
x1:=left+width;  
x2:=left;  
end;  
y1:=top+height*i/(ny+1);  
y2:=y1+(width*sin(Theta)/abs(cos(Theta)));  
if y2>top+height then begin  
y2:=top+height;  
x2:=x1+((y2-y1)*cos(Theta)/sin(Theta)); 
end;  
{{{plength is the length of the line to be drawn in pixels}}}  
plength:=sqrt(sqr(x2-x1)+sqr((y2-y1)/AspectRatio));  
valx:=x1;  
valy:=y1;  
dx:=(x2-x1)/plength;  
dy:=(y2-y1)/plength;  
switch:=true;  
if plength>=MinDim then begin  
LineSum:=LineSum+(plength/scale);  
for k:=0 to plength do begin  
if GetPixel(x1+k*dx,y1+k*dy)>0  
then indicator:=true  
else indicator:=false;  
if (switch=true) and (indicator=true) then begin  
Intercepts:=Intercepts+1;  
switch:=false;  
end;  
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if (indicator=false) then switch:=true;  
end;  
end;  
end;{{{i}}}  
IntLength:=LineSum/Intercepts;  
dummy:=rUser2[j+1];  
rUser1[j+1]:=180*Theta/PI;  
{{{to do cumulative measurements, type in 'dummy+ before Intlength in the next line}}}  
rUser2[j+1]:=IntLength*1000;  
end; {{{j}}}  
ShowResults;  
end;  
macro 'Linear Intercept +'  
{{{This macro measures the linear intercept distance over a giver ROI  
at intervals of angle}}}  
var  
left,top,width,height,MinDim,nx,ny,i,j,k:integer;  
ThetaStep,NSteps,PI,x1,x2,y1,y2,dy,dx:real;  
Theta,valx,valy,plength,scale,AspectRatio:real;  
IntLength,LineSum,dummy:real;  
Intercepts:integer;  
switch,indicator:boolean;  
unit:string;  
begin  
SetOptions('User1;User2');  
GetRoi(left,top,width,height);  
if width=0 then begin  
PutMessage('Selection required.');  
exit;  
end;  
if width<height then MinDim:=width  
else MinDim:=height;  
PI:=3.141592654;  
GetScale(scale,unit,AspectRatio);  
NSteps:=18;{{{GetNumber('Enter # steps between 0 and 90 deg.',3,0);}}}  
ThetaStep:=PI/(2*NSteps);  
{{{block out next line when doing cumulative measurements}}}  
{{{SetCounter(2*NSteps);}}}  
SetUser1Label('Theta(rad)');  
SetUser2Label('Lx10^3');  
for j:=0 to 2*NSteps-1 do begin  
LineSum:=0;  
Intercepts:=0;  
x1:=left;  
y1:=top;  
Theta:=j*ThetaStep;  
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nx:=10*sin(Theta)*width/height;  
ny:=10*abs(cos(Theta));  
for i:=0 to nx do begin  
if Theta=0 then begin  
x1:=left;  
x2:=x1+width;  
end else begin  
x1:=left+(width*i/(nx+1))+width/(2*(nx+1));  
x2:=x1+(height*cos(Theta)/sin(Theta));  
end;  
y2:=top+height;  
if x2>=left+width then begin  
x2:=left+width;  
y2:=y1+(x2-x1)*sin(Theta)/cos(Theta);  
end else if x2<left then begin  
x2:=left;  
if Theta>PI/2 then y2:=y1+(x2-x1)*sin(Theta)/cos(Theta);  
end;  
{{{plength is the length of the line to be drawn in pixels}}}  
plength:=sqrt(sqr(x2-x1)+sqr((y2-y1)/AspectRatio));  
valx:=x1;  
valy:=y1;  
dx:=(x2-x1)/plength;  
dy:=(y2-y1)/plength;  
switch:=true;  
if plength>=MinDim then begin  
LineSum:=LineSum+(plength/scale);  
for k:=0 to plength do begin  
if GetPixel(x1+k*dx,y1+k*dy)>0  
then indicator:=true  
else indicator:=false;  
if (switch=true) and (indicator=true) then begin  
Intercepts:=Intercepts+1;  
switch:=false;  
end;  
if (indicator=false) then switch:=true;  
end;  
end;  
end;  
for i:=1 to ny do begin  
if Theta<=PI/2 then begin  
x1:=left;  
x2:=left+width  
end else begin  
x1:=left+width;  
x2:=left;  
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end;  
y1:=top+height*i/(ny+1);  
y2:=y1+(width*sin(Theta)/abs(cos(Theta)));  
if y2>top+height then begin  
y2:=top+height;  
x2:=x1+((y2-y1)*cos(Theta)/sin(Theta));  
end;  
{{{plength is the length of the line to be drawn in pixels}}}  
plength:=sqrt(sqr(x2-x1)+sqr((y2-y1)/AspectRatio));  
valx:=x1;  
valy:=y1;  
dx:=(x2-x1)/plength;  
dy:=(y2-y1)/plength;  
switch:=true;  
if plength>=MinDim then begin  
LineSum:=LineSum+(plength/scale);  
for k:=0 to plength do begin  
if GetPixel(x1+k*dx,y1+k*dy)>0  
then indicator:=true  
else indicator:=false;  
if (switch=true) and (indicator=true) then begin  
Intercepts:=Intercepts+1;  
switch:=false;  
end;  
if (indicator=false) then switch:=true;  
end;  
end;  
end;{{{i}}}  
IntLength:=LineSum/Intercepts;  
dummy:=rUser2[j+1];  
rUser1[j+1]:=180*Theta/PI;  
{{{to do cumulative measurements, type in 'dummy+ before Intlength in the next line}}}  
rUser2[j+1]:=dummy+IntLength*1000;  
end; {{{j}}}  
ShowResults;  
end;  
Macro 'Plot Intercepts'  
{{{This macro plots the linear intercept distance as a function of angle  
in cylindrical coordinates  
It then finds the best-fit ellipse to a set of linear intercept distance vs. angle data  
using multiple linear regression of the equation Y=C0+C1*X+C2*Z, where  
Y=1/L^2 , where L is one half the linear intercept distance at Theta  
X=cosine(2*Theta), Z=sine(2*Theta)  
C0=(Mii+Mjj)/2 , C1=(Mii-Mjj)/2 , C2=Mij.  
The objective is to solve for M11, Mjj, and Mij  
The best-fit ellipse it then plotted on top of the linear intercept measurements}}}  
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var  
left,top,width,height,X0,Y0,X1,Y1,i,n:integer;  
pscale,aspectRatio,dx1,dx2,dy1,dy2,maxdim:real;  
unit:string;  
sumX,sumY,sumZ,sumXZ,sumXY,sumYZ,sumZsqr,sumXsqr:real;  
C0,C1,C2,Mii,Mjj,Mij,Y,X,Z,PI,Theta1,Theta2,L1,L2:real;  
begin  
PI:=3.141592654;  
SaveState;  
SetForegroundColor(255);  
SetBackgroundColor(0);  
width:=400;  
height:=400;  
maxdim:=0;  
for i:=1 to rCount do begin  
if rUser2[i]>maxdim then maxdim:=rUser2[i];  
end;  
pscale:=.8*(width+height)/(2*maxdim);  
SetNewSize(width,height);  
MakeNewWindow('Linear Intercepts vs. Theta');  
SetLineWidth(1);  
X0:=(width/2);  
Y0:=(height/2);  
MakeLineROI(0,Y0,width,Y0);  
Fill;  
MakeLineROI(X0,0,X0,height);  
Fill;  
for i:=1 to rCount do begin  
dx1:=pscale*0.5*rUser2[i]*cos(rUser1[i]*PI/180);  
dy1:=pscale*0.5*rUser2[i]*sin(rUser1[i]*PI/180);  
if i<rCount then begin  
dx2:=pscale*0.5*rUser2[i+1]*cos(rUser1[i+1]*PI/180);  
dy2:=pscale*0.5*rUser2[i+1]*sin(rUser1[i+1]*PI/180);  
end else begin  
dx2:=-pscale*0.5*rUser2[1]*cos(rUser1[1]*PI/180);  
dy2:=-pscale*0.5*rUser2[1]*sin(rUser1[1]*PI/180);  
end;  
MoveTo(X0+dx1,Y0+dy1);  
LineTo(X0+dx2,Y0+dy2);  
MoveTo(X0-dx1,Y0-dy1);  
LineTo(X0-dx2,Y0-dy2);  
end;  
n:=rCount;  
sumX:=0;  
sumY:=0;  
sumZ:=0;  
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sumXY:=0;  
sumYZ:=0;  
sumXZ:=0;  
sumZsqr:=0;  
sumXsqr:=0;  
for i:=1 to n do begin  
Y:=1/(sqr(rUser2[i]/2));  
X:=cos(2*PI*rUser1[i]/180);  
Z:=sin(2*PI*rUser1[i]/180);  
sumX:=sumX+X;  
sumY:=sumY+Y;  
sumZ:=sumZ+Z;  
sumXY:=sumXY+(X*Y);  
sumYZ:=sumYZ+(Y*Z);  
sumXZ:=sumXZ+(X*Z);  
sumZsqr:=sumZsqr+sqr(Z);  
sumXsqr:=sumXsqr+sqr(X);  
end;  
C1:=((sumXY*sumZsqr)-(sumXZ*sumYZ))/((sumXsqr*sumZsqr)-sqr(sumXZ));  
C2:=((sumYZ*sumXsqr)-(sumXY*sumXZ))/((sumXsqr*sumZsqr)-sqr(sumXZ));  
C0:=(sumY/n)-C1*(sumX/n)-C2*(sumZ/n);  
for i:=1 to rCount do begin  
Theta1:=rUser1[i]*PI/180;  
if i<rCount then Theta2:=rUser1[i+1]*PI/180  
else Theta2:=rUser1[1]*PI/180;  
L1:=1/sqrt(C0+C1*cos(2*Theta1)+C2*sin(2*Theta1));  
L2:=1/sqrt(C0+C1*cos(2*Theta2)+C2*sin(2*Theta2));  
dx1:=pscale*L1*cos(Theta1);  
dy1:=pscale*L1*sin(Theta1);  
if i<rCount then begin  
dx2:=pscale*L2*cos(Theta2);  
dy2:=pscale*L2*sin(Theta2);  
end else begin  
dx2:=-pscale*L2*cos(Theta2);  
dy2:=-pscale*L2*sin(Theta2);  
end;  
MoveTo(X0+dx1,Y0+dy1);  
LineTo(X0+dx2,Y0+dy2);  
MoveTo(X0-dx1,Y0-dy1);  
LineTo(X0-dx2,Y0-dy2);  
end;  
NewTextWindow('Results');  
write(C0:8:8', ');  
write(C1:8:8', ');  
write(C2:8:8);  
end;  
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macro 'Count Black and White Pixels [B]';  
{{{  
Counts the number of black and white pixels in the current  
selection and stores the counts in the User1 and User2 columns.  
}}}  
begin  
RequiresVersion(1.44);  
SetUser1Label('Black');  
SetUser2Label('White');  
Measure;  
rUser1[rCount]:=histogram[255];  
rUser2[rCount]:=histogram[0];  
UpdateResults; 
end;  
macro 'Compute Percent Black and White';  
{{{  
Computes the percentage of back and white pixels in the  
current selection. This macro only works with binary images.  
}}}  
var  
nPixels,mean,mode,min,max:real;  
begin  
RequiresVersion(1.44);  
SetUser1Label('Black');  
SetUser2Label('White');  
Measure;  
GetResults(nPixels,mean,mode,min,max);  
rUser1[rCount]:=histogram[255]/nPixels;  
rUser2[rCount]:=histogram[0]/nPixels;  
UpdateResults;  
if (histogram[0]+histogram[255])<>nPixels  
then PutMessage('This macro requires a binary image.');  
end;  
macro 'Compute Area Percentage [P]';  
{{{  
Computes the percentage of foreground  
pixels in the current selection.  
}}}  
var  
mean,mode,min,max:real;  
i,lower,upper,fPixels,nPixels,count:integer;  
begin  
RequiresVersion(1.50);  
SetUser1Label('%');  
Measure;  
GetResults(nPixels,mean,mode,min,max);  
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GetThresholds(lower,upper);  
if (lower=0) and (upper=0) and  
((histogram[0]+histogram[255])<>nPixels)  
then begin  
PutMessage('This macro requires a binary or thresholded image.');  
exit;  
end;  
if nPixels=0 then begin  
end;  
if (lower=0) and (upper=0) then begin  
if nPixels=0  
then rUser1[rCount]:=0  
else rUser1[rCount]:=(histogram[255]/nPixels)*100;  
UpdateResults;  
exit;  
end;  
fPixels:=0;  
nPixels:=0;  
for i:=0 to 255 do begin  
count:=histogram[i];  
nPixels:=nPixels+count;  
if (i>=lower) and (i<=upper)  
then fPixels:=fPixels+count;  
end;  
rUser1[rCount]:=(fPixels/nPixels)*100;  
UpdateResults;  
end; 
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A.9: Measurement of Mineral Gradient Protocol 
Supplies and equipment 
• XradiaBioCT and associated software 
• MATLAB 
• Multi-compartment sample to scan 
• Tweezers 
 
XradiaBioCT Procedure 
 
1. Turn on camera and light. 
2. Turn on X-Ray (25 kEv and 5 W) 
3. Align sample in an upright position, clamped by the sample stage, such that the interface 
is horizontal. 
4. Align sample in the y-direction so that the interface of the multi-compartment scaffold is 
centered.  
5. Align sample in the x-direction. (Find sample edges, note position, and take the average. 
This is where the sample center is.) 
6. Rotate sample to 90 degrees, and -90 degrees, in order to align the sample in the z-
direction. (Note the sample edges at both 90 degree positions. Add the sample edge 
positions and divide by two, then move the sample by that much such that it is centered.) 
7. Ensure that exposure time gives a pixel intensity value of close to 10,000 (6 second 
exposure time) 
8. Capture the sample position coordinates for use in the recipe creation. 
9. Run the sample recipe such that a scan is taken every ¼ degree (typically 753 scans). 
10. Save sample name and hit “run”. 
11. After the scan is finished, take a reference picture at the same settings but without the 
sample, and apply it to the scan. 
12. Calibrate the center shift of the sample (usually around 12 pixels) 
13. Adjust the contrast as desired, and export as a series of tiff images for further processing 
and analysis. 
 
MATLAB tiff series compilation code 
 
%Dan Reilly helped to write this code 
%This script is meant to load microCT tiff images in series and combine 
%them into a single matrix, which can then be saved for future analysis 
  
clear all; 
  
%Uses multiple processors to run code in parallel 
if matlabpool('size') == 0            % checking to see if my pool is already open 
    matlabpool open; 
end 
  
%This is the location of all of the files you want to 
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folder='Z:\03252014\Tiff Slices XY\'; 
  
%Base file name, where all other files simply have a number added on at the 
%end 
image_file_title_base = 'Flat interface 2 hour_Tomo_AreaA_Recon_XY_Export'; 
  
%Numbers range that are on the end of the file names 
file_nums=[0001:1013]; 
  
%Initializing future matrices 
number_of_files=length(file_nums); 
file_nums1=cell(number_of_files,1); 
image_file=cell(number_of_files,1); 
  
%converting integer file numbers to 4 digit strings and saving into cells 
for nf=1:length(file_nums) 
    file_nums1{nf}=sprintf('%04d',file_nums(nf)); 
end 
  
%Creating the series of image names 
for nf=1:length(file_nums) 
    image_file{nf}=[folder image_file_title_base file_nums1{nf} '.tif']; 
end 
  
%initializes basic image information 
image_info=imfinfo(image_file{nf}); 
xpix=image_info.Width; 
ypix=image_info.Height; 
  
%Loop that actually creates the 3-dimensional matrix 
combined_images=uint8(zeros(ypix,xpix,number_of_files)); 
for nf=1:length(file_nums) 
    disp(nf)                                                      %displays file number we are on 
    CT_image=rgb2gray(imread(image_file{nf},'info',image_info)); 
    combined_images(:,:,nf)=CT_image; 
end 
  
%saves 3D matrix and all additional variables to a folder for future 
%analysis 
save([folder image_file_title_base]) 
 
MATLAB interface width determination code 
 
clear all; 
  
%Loading files and renaming images for use during analysis 
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folder='C:\Users\laura_000\Documents\Grad School\Research\MicroCT MATLAB\'; 
image_file_title_base = 'Flat Interface Abs 0 sample 2_XY_Export'; 
load([folder image_file_title_base]) 
  
%make average array, where we are averaging across the Z-direction 
avg_im=mean(combined_images,3); 
  
%linescan for non-mineral content 
non_mineral_line = avg_im(100,100:900); 
non_mineral_avg = mean(non_mineral_line); 
non_mineral_sd = std(non_mineral_line); 
  
%linescan for mineral content 
mineral_line=avg_im(900,100:900); 
mineral_avg = mean(mineral_line); 
mineral_sd = std(mineral_line); 
  
%linescan across interface  
interface_start=zeros(61,1); 
interface_end=zeros(61,1); 
interface_length=zeros(61,1); 
  
for j=200:10:800 
    num_lines=10; 
    space=50;       %space before end 
    line_comp=zeros(length(avg_im(:,1))-100-space+1,num_lines); 
     
    for i=1:num_lines 
        line_comp(:,i)=avg_im(100:end-space,j+i); 
    end 
     
    line_avg=mean(line_comp,2); 
    line=smooth(line_avg,7); 
     
     
    for i=1:length(line) 
        if line(i)>non_mineral_avg+2*non_mineral_sd 
            interface_start(j/10-19)=i; 
            break 
        end 
    end 
     
    for i=length(line):-1:1 
        if line(i)<mineral_avg-1.5*mineral_sd 
            interface_end(j/10-19)=i; 
            break 
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        end 
    end 
       
     
end 
    
interface_length=interface_end - interface_start; 
interface_avg = mean(interface_length); 
interface_sd = std(interface_length); 
  
%to view image, use command imshow(imadjust(uint8((avg_im)))) 
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A.10: Benzophenone Functionalization 
References: (Martin et al. 2011) 
 
Reagents 
• Dimethylformamide (DMF) (Sigma) 
• N-Diisopropylethylamine (DIEA) (Sigma) 
• Benzophenone (BP) (Invitrogen) 
• Sterile phosphate-buffered saline (PBS) 
• 200 proof (100%) ethanol 
• ConA biotin 
• 0.5% pluronic acid solution in PBS 
 
Supplies and equipment 
• Glass scintillation vials 
• Aluminum foil 
• Conical centrifuge tubes (15 mL) 
• Kimwipes 
• Sterile blunt-nosed tweezers 
• MTS 2/4 digital microtiter shaker (IKA 3208001) 
 
Procedure 
 
1. Add 100 mg of BP to 10 mL of DMF and 500 μL DIEA in glass scintillation vial covered 
in foil. (NOTE: Do not use plastic) 
2. Place membranes into BP solution and let sit in the dark at room temperature for 48 
hours. 
3. Remove BP solution and rinse with multiple DMF washes until membranes are no longer 
yellow and appear white. 
4. Rinse membranes in ethanol for 1 hour. Replace ethanol and leave membranes overnight. 
5. Rinse membranes in PBS for 1 hour. Replace PBS and leave membranes overnight. 
6. Prepare the protein solution in PBS to desired concentration (typically 1 mg/mL to 5 
mg/mL) 
7. In dark, remove membrane from PBS and remove excess solution by dabbing membrane 
on Kimwipe. 
8. Place membrane on glass coverslip on top of a glass slide 
9. Add 10 μL of protein to the membrane and place coverslip on top (forming a coverslip 
sandwich) If mask is to be used, place on top of top coverslip 
10. Turn on the laser and expose the membrane at 365 nm with intensity between 18-20 mW 
for the desired time. 
11. Make sure the protein loading time between samples are the same. (i.e. protein should be 
left in membranes for 10 min despite exposure times). 
12. After protein loading time has expired, dry membrane with Kimwipe and place in 2 mL 
of pluronic acid. 
13. After a minimum of 1 hour, remove membrane from pluronic acid solution and rinse 
under moderate shaking at room temperature in desired wash solution overnight. 
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14. Rinse membrane under moderate shaking at room temperature in PBS for 1 hour. 
15. Add 1 μL of AlexaFluor 488 labeled streptavidin in 2 mL 3% BSA in PBS to each well 
with membrane in a 24 well plate. 
16. Let samples label under moderate shaking for 1 hour at room temperature. 
17. Remove solution and rinse membranes with 2 mL PBS for a minimum of 1 hour. 
18. Analyze samples as described in A.16 or A.17. 
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A.11: HMSC Culture Protocol 
Reference: Protocols from Matt Wheeler group and Jennie P. Mather  
 
Reagents  
• Complete hMSC media (500 mL); store at 4 °C  
o 445 mL low glucose DMEM (Based on Fisher SH30022.FS, order from Sandy at 
SCS Media Facility); store at 4 °C  
o 50 mL MSC-validated fetal bovine serum (Invitrogen); store at -20 °C  
o 5 mL antibiotic-antimyotic (Invitrogen 15140-122); store at -20 °C  
• Trypsin-EDTA (Invitrogen 25300-062); store at -20 °C  
• Trypan blue (Sigma-Aldrich T8154)  
• DMSO (Fisher D128-500)  
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS)  
 
Supplies and equipment  
• Hausser phase contrast hemacytometer (Fisher 02-671-5)  
• Tabletop centrifuge (VWR 53513-812)  
• Optical microscope (Leica Microsystems DMIL LED)  
• Water bath (37 °C, Fisher 15-474-35)  
• Sterile filters  
• Sterile pipettes (5, 10, 25 mL)  
• T75 tissue culture flasks  
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted.  
 
MSC thawing procedure  
 
1. Place complete MSC media in water bath and warm to 37 °C.  
2. Thaw frozen cell vials in 37 °C water bath for about 2 min.  
3. Transfer the thawed cells and freezing media to a 15 mL centrifuge tube. Add complete 
MSC media until the cerulean effect has dissipated, then bring the volume up to 9 mL. 
4. Remove a 10 µL cell suspension aliquot for counting. Gently re-suspend the cells in the 
diluted media and pellet the cells at 600 g for 5 min.  
5. While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of 
Trypan blue. Pipette several times to mix the stain and cell suspension.  
6. Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension 
into the hemocytometer.  
7. Cell counts are performed in as many of the nine separate regions of the hemocytometer 
as is feasible. Average number of cells per region is used to calculate the total cell 
population. For this calculation, the dilution factor is typically 2 (1:1 ratio of cell 
suspension to Trypan blue).  
 
Total Cell Population = (Mean Cells/Region) * Dilution * 10,000 * (Cell Suspension Volume) 
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8. Seed the cells at the required density (usually 5,000-6,000 cells/cm2). Use around 10-12 
mL media for a 100 mm dish, 12-14 mL for a T75, or 7-8 mL for a T25.  
9. Place the flask(s) into the incubator. Check the confluence every 24 hours and feed cells 
twice a week. Cells are usually confluent after 7-9 days. Do not use past passage 6.  
 
MSC feeding procedure  
 
1. Warm complete MSC media in water bath to 37 °C.  
2. When the media is warm, wipe dry with paper towel and spray with 70% ethanol before 
placing in the sterile hood.  
3. Remove all old media from each flask or well plate, taking care not to scrape the cells 
with the pipette tip.  
4. Add appropriate volume of media. Return the flasks or well plates to the incubator and 
feed every twice a week. Adjust volume of media accordingly for different sized 
containers.  
 
MSC passaging procedure 
 
1. Warm complete MSC media, sterile PBS, and 3 mL trypsin-EDTA per T75 flask to be 
passaged in water bath to 37 °C.  
2. When the media, PBS and trypsin are warm, wipe them dry with paper towel and spray 
with 70% ethanol before placing in the sterile hood.  
3. Remove all old media from each T75 flask, taking care not to scrape the cells with the 
pipette tip.  
4. Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. Adjust volumes of PBS, media, 
and trypsin accordingly for different sized flasks.  
5. Remove the PBS and add 3 mL of trypsin per T75 flask. Return the flasks to the 
incubator for 8 min to allow for the cells to detach from the tissue culture plastic (allow 
the cells to sit for 3-4 additional min in the incubator if they do not detach after 6 min). 
Slap flasks a few times to detach cells.  
6. Add 6 mL of complete MSC media to each flask to neutralize the trypsin and to flush 
cells off of the tissue culture plastic.  
7. Remove the trypsin, additional media, and cells from the flask and put into a conical tube. 
Remove a 10 µL cell suspension aliquot for counting. Centrifuge the cells at 600 g for 5 
min.  
8. While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of 
Trypan blue. Pipette several times to mix the stain and cell suspension.  
9. Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension 
into the hemocytometer.  
10. Cell counts are performed in as many of the nine separate regions of the hemacytometer 
as is feasible. Average number of cells per region is used to calculate the total cell 
population. For this calculation, the dilution factor is typically 2 (1:1 ratio of cell 
suspension to Trypan blue).  
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Total Cell Population = (Mean Cells/Region) * Dilution * 10,000 * (Cell Suspension Volume) 
 
11. Aspirate off the media supernatant and add new media to dilute cells to desired 
concentration.  
12. Seed the cells at the required density (usually 5,000-6,000 cells/cm2). Use around 10-12 
mL media for a 100 mm dish, 12-14 mL for a T75, or 7-8 mL for a T25.  
13. Place the flask(s) into the incubator. Check the confluence every 24 hours and feed cells 
twice a week.  
 
MSC freezing procedure  
 
1. Grow cells to confluence and replace media the day before freezing.  
2. Warm complete MSC media, sterile PBS, and 3 mL trypsin-EDTA per T75 flask to be 
passaged in water bath to 37 °C.  
3. When the media, PBS and trypsin are warm, wipe them dry with paper towel and spray 
with 70% ethanol before placing in the sterile hood.  
4. Remove all old media from each flask, taking care not to scrape the cells with the pipette 
tip.  
5. Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. Adjust volumes of PBS, media, 
and trypsin accordingly for different sized flasks.  
6. Remove the PBS and add 3 mL of trypsin per T75 flask. Return the flasks to the 
incubator for 8 min to allow for the cells to detach from the tissue culture plastic (allow 
the cells to sit for 3-4 additional min in the incubator if they do not detach after 6 min). 
Slap flasks a few times to detach cells.  
7. Add 6 mL of complete MSC media to each flask to neutralize the trypsin and to flush 
cells off of the tissue culture plastic.  
8. Remove the trypsin, additional media, and cells from the flask and put into a conical tube. 
Remove a 10 µL cell suspension aliquot for counting. Centrifuge the cells at 600 g for 5 
min.  
9. While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of 
Trypan blue. Pipette several times to mix the stain and cell suspension.  
10. Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension 
into the hemocytometer.  
11. Cell counts are performed in as many of the nine separate regions of the hemocytometer 
as is feasible. Average number of cells per region is used to calculate the total cell 
population. For this calculation, the dilution factor is typically 2 (1:1 ratio of cell 
suspension to Trypan blue). 
 
Total Cell Population = (Mean Cells/Region) * Dilution * 10,000 * (Cell Suspension Volume) 
 
12. Aspirate off the media supernatant and calculate volume of freezing media needed to re-
suspend 1-10 x 106 cells per mL (freezing media: 50% complete MSC media, 40% FBS, 
10% DMSO).  
13. Aliquot cells into 1 mL cryogenic tubes and place in -20 °C freezer for 1 hour.  
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14. Place cryogenic tubes in -80 °C freezer. Cells can be stored here for up to 6 months. For 
longer-term storage, keep cells at -80 °C for at least 24 hours and then carefully move to 
liquid nitrogen storage in IGB. 
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A.12: Cell Seeding on Multi-Compartment CG-CGCaP Scaffolds 
Reference: (Caliari and Harley 2011; Caliari, Ramirez et al. 2011)  
 
Reagents  
• Complete media (see A.6 protocol for recipe); store at 4 °C  
• Trypsin-EDTA (Invitrogen 25300-062); store at -20 °C  
• Trypan blue (Sigma-Aldrich T8154)  
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS)  
 
Supplies and equipment  
• Ultra-low attachment 6-well plates (Fisher 07-200-601)  
• Hausser phase contrast hemacytometer (Fisher 02-671-5)  
• Tabletop centrifuge (VWR 53513-812)  
• Optical microscope (Leica Microsystems DMIL LED)  
• Water bath (37 °C, Fisher 15-474-35)  
• Sterile pipettes (5, 10, 25 mL)  
• Kimwipes  
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted. For 
growth factor supplemented studies, use tendon cell media without serum.  
 
Procedure  
 
1. Warm complete media, sterile PBS, and 3 mL trypsin-EDTA per T75 flask to be 
passaged in water bath to 37 °C.  
2. Place hydrated scaffold pieces in fresh media for at least 30 min.  
3. Carefully remove excess media from scaffolds with a Kimwipe and place 3-4 scaffolds in 
each well of Ultra-low attachment 6-well plates. Do not overdry scaffolds (especially 
CGCaP scaffolds) as this will lead to reduced viability.  
4. When the media, PBS and trypsin are warm, wipe them dry with paper towel and spray 
with 70% ethanol before placing in the sterile hood. 
5. Remove all old media from each flask, taking care not to scrape the cells with the pipette 
tip.  
6. Add 10 mL of PBS per T75 flask and leave the PBS in the flask to rinse the cells for 30 s. 
Swirl gently to remove any excess media from the cells. Adjust volumes of PBS, media, 
and trypsin accordingly for different sized flasks.  
7. Remove the PBS and add 3 mL of trypsin per flask. Return the flasks to the incubator for 
6-8 min to allow for the cells to detach from the tissue culture plastic (allow the cells to 
sit for 3-4 additional min in the incubator if they do not detach after 6 min). Slap flasks a 
few times to detach cells.  
8. Add 6 mL of complete tendon cell media to each flask to neutralize the trypsin and to 
flush cells off of the tissue culture plastic.  
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9. Remove the trypsin, additional media, and cells from the flask and put into a conical tube. 
Remove a 10 µL cell suspension aliquot for counting. Centrifuge the cells at 600 g for 5 
min.  
10. While cells are spinning down, mix the 10 µL cell suspension aliquot with 10 µL of 
Trypan blue. Pipette several times to mix the stain and cell suspension.  
11. Place a cover slip on the hemocytometer and pipette 10 µL of the stain/cell suspension 
into the hemocytometer.  
12. Cell counts are performed in as many of the nine separate regions of the hemocytometer 
as is feasible. Average number of cells per region is used to calculate the total cell 
population. For this calculation, the dilution factor is typically 2 (1:1 ratio of cell 
suspension to Trypan blue).  
 
Total Cell Population = (Mean Cells/Region) * Dilution * 10,000 * (Cell Suspension Volume)  
 
13. Aspirate off the media supernatant and add new media to dilute cells to desired 
concentration. For 8 mm diameter, 5 mm thick scaffold pieces dilute to 1-5 x 105 cells per 
20-40 µL media.  
14. Add 10-20 µL of cell suspension to each scaffold. Place scaffolds in incubator for 15-30 
min.  
15. Remove scaffolds from incubator, flip over, add additional 10-20 µL of cell suspension to 
the other side of each scaffold, and return to incubate for additional 2-3 hours.  
16. Carefully add 6 mL complete media (or media with growth factors but without serum) to 
each well. Change media every 3 days over the course of the experiment. 
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A.13: AlamarBlue Metabolic Activity Protocol 
Reference: (Tierney, Jaasma et al. 2009; Caliari and Harley 2011; Caliari, Ramirez et al. 2011)  
 
Reagents  
• Complete media (see A.10 for recipe); store at 4 °C  
• AlamarBlue (Invitrogen DAL1100); store at 4 °C  
 
Supplies and equipment  
• 24-well plates (Fisher 08-772-1)  
• 96-well plates (Fisher 12-565-369)  
• MTS 2/4 digital microtiter shaker (IKA 3208001)  
• Water bath (37 °C, Fisher 15-474-35)  
• Fluorescence spectrophotometer (Tecan, Room 299 RAL)  
 
Procedure 
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted. The 
volumes of reagents used are correct for 8 mm diameter, 5 mm thick scaffold pieces. Use 
identical media to that being used for experiment.  
 
Generating standard curve procedure  
 
1. Warm media and alamarBlue in water bath to 37 °C.  
2. Before starting an experiment, generate a standard curve with a known number of cells. 
The standard should have at least eight sample points: one well with just media, one well 
with media and alamarBlue, and six wells with media, alamarBlue, and a different 
number of cells. An example standard setup is shown: 
 
 
Well 1 is a negative control, well 2 is a background control, and the other wells are used to make 
the standard curve.  
 
3. Incubate at 37 °C under gentle (~50 rpm) shaking for 1.5-5.5 hours. During this time 
healthy cells convert the active ingredient in alamarBlue (resazurin) to the highly 
fluorescent resorufin. Longer incubation times are necessary for smaller cell 
concentrations, but make sure not to incubate cells too long or all of the resazurin will be 
reduced to resorufin.  
4. After incubation, pipette 100 µL in triplicate from each sample well into a clear 96-well 
plate. 
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5. Measure fluorescence (excitation: 540 nm, emission: 580 nm) on the spectrophotometer 
in RAL using the program ‘AlamarBlue F200’. Remember to reserve the F200 machine 
on the Google Calendar prior to use. For each data point, adjust the fluorescence reading 
by subtracting the reading from well 2 (background control). The standard curve is 
created by plotting cell number as a function of adjusted fluorescent intensity.  
 
Quantifying metabolic activity on scaffolds procedure 
 
1. For measuring cell metabolic activity on scaffolds, pipette 900 µL media into each well 
(one well for each scaffold piece plus the two control wells). Add 100 µL alamarBlue to 
each well except for one negative control well. Adjust volumes for smaller/larger 
materials accordingly, keeping the 9:1 media: alamarBlue® ratio constant.  
2. Remove scaffolds to be assayed and rinse in sterile PBS to remove excess media and 
unattached/dead cells. Add scaffolds to experimental wells and incubate at 37 °C under 
gentle (~50 rpm) shaking for 1.5-5.5 hours. The incubation time should be identical to the 
time used to make the standard curve.  
3. After incubation, pipette 100 µL in triplicate from each sample well into a 96-well plate.  
4. Measure fluorescence (excitation: 540 nm, emission: 580 nm) on the spectrophotometer 
in RAL 299 using the program ‘AlamarBlue F200’. Remember to reserve the F200 
machine on the Google Calendar prior to use. Subtract the background control from the 
data points and extrapolate adjusted fluorescent intensity on the standard curve to give 
metabolic activity.  
5. This assay is non-destructive, so scaffolds can continue to be cultured and analyzed at 
later time points. 
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A.14: DNA Quantification (Hoechst Dye) Protocol 
Reference: (Kim, Sah et al. 1988; Caliari and Harley 2011; Caliari, Ramirez et al. 2011)  
 
Reagents  
• Hoechst dye buffer (500 mL); store at 4 °C for up to 3 months  
o 400 mL deionized water  
o 58.44 g sodium chloride  
o 0.605 g Tris base  
o 0.185 g disodium EDTA (Sigma-Aldrich E5134)  
o Adjust pH to 7.4, bring total volume to 500 mL, sterile filter before use  
• Papain buffer (100 mL); store at 4 °C  
o 100 mL PBS  
o 1 mL 0.5 M EDTA (pH = 8.0, Sigma-Aldrich EDS); store at 4 °C  
o 79 mg cysteine-HCl (Sigma-Aldrich 00320)  
• Hoechst 33258 dye solution (1 mL); store at 4 °C for up to 6 months  
o 1 mL sterile water  
o 1 mg Hoechst 33258 dye (Invitrogen H1398); store at 4 °C  
• Papain from Carica papaya (Sigma-Aldrich 76218); store at -20 °C  
• Sterile phosphate-buffered saline without Ca2+ or Mg2+ (PBS)  
 
Supplies and equipment  
• 96-well plates (Fisher 12-565-369)  
• Vortex (Fisher 02-215-365)  
• Water bath (60°C, Fisher 15-460-2SQ)  
• Fluorescence spectrophotometer (Tecan, Room 299 RAL)  
• Microcentrifuge tubes (1.5 mL)  
 
Generating standard curve procedure  
 
*Note: steps 1-2 should be performed in the laminar flow hood.  
 
1. At the beginning of each experiment, a standard curve should be generated with a known 
number of cells. To make a standard curve spanning 5 x 103 to 1.5 x 106 million cells, 
make up active papain enzyme solution by dissolving 18-20 mg papain in 15 mL papain 
buffer in the 60 °C water bath.  
2. Spin down two aliquots of 2 million cells each. Remove supernatant and add 12 mL 
papain enzyme solution to one tube and 400 µL to the other tube. Allow to digest for 24 
hours in the 60 °C water bath.  
3. After 24 hours, vortex tubes thoroughly. For the 12 mL tube, add cell lysate to labeled 
microcentrifuge tubes in 30 µL intervals (starting from a blank control) up to 300 µL. 
Bring all volumes to 300 µL with blank papain buffer. For the 400 µL tube, add cell 
lysate to labeled microcentrifuge tubes in 2 µL intervals (starting from a blank control) 
up to 30 µL. Bring all volumes to 30 µL with blank papain buffer.  
4. Prepare Hoechst working dye solution by adding 1 µL dye solution to 10 mL Hoechst 
dye buffer. Vortex thoroughly. Add working dye solution to each tube to bring total 
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volume to 630 µL. Vortex thoroughly. The Hoechst dye fluorescently binds to double-
stranded DNA from the lysed cells, allowing quantification of DNA and thus cell 
number.  
5. Pipette 200 µL from each tube in triplicate into a black 96-well plate.  
6. Measure fluorescence (excitation: 360 nm, emission: 465 nm) on the spectrophotometer 
in RAL 299. Use the ‘DNA F200’ program and remember to reserve the F200 machine 
on the Google Calendar prior to use. For each data point, adjust the fluorescence reading 
by subtracting the reading from the blank control. The standard curve is created by 
plotting cell number as a function of adjusted fluorescent intensity.  
 
Quantifying cell number on scaffolds procedure  
 
*Note: step 2 should be performed in the laminar flow hood. 
  
1. For measuring cell number on scaffolds, pipette 300 µL of papain enzyme solution into 
microcentrifuge tubes (one for each scaffold plus two controls: one tube with just papain 
enzyme solution as a negative control and one tube containing a blank scaffold with no 
seeded cells as a background control).  
2. Remove scaffolds to be assayed and rinse in sterile PBS to remove excess media and 
unattached/dead cells. Add scaffolds to microcentrifuge tubes and incubate in 60 °C 
water bath for 24 hours. Vortex occasionally to facilitate digestion of scaffold.  
3. After incubation, pipette 600 µL Hoechst working dye solution in microcentrifuge tubes.  
4. Remove samples from water bath and vortex thoroughly. Add 30 µL from each tube to its 
corresponding tube containing working dye solution. Vortex thoroughly.  
5. Pipette 200 µL from each tube in triplicate from each sample well into a 96-well plate.  
6. Measure fluorescence (excitation: 360 nm, emission: 465 nm) on the spectrophotometer 
in RAL 299. Use the ‘DNA F200’ program and remember to reserve the F200 machine 
on the Google Calendar prior to use. For each data point, adjust the fluorescence reading 
by subtracting the reading from the background control. Adjusted fluorescent intensity 
can be extrapolated on the standard curve to give a cell number. 
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A.15: Multi-Compartment Scaffold Straining 
Reference: (Legerlotz et al. 2011) 
 
Reagents: 
• Complete media (see A.11 for recipe); store at 4 °C 
• CG-CGCaP scaffolds (hydrated and seeded with cells. see A.11) 
 
Supplies and equipment: 
• BOSE loading frame (BOSE Corporation, Eden, Prairie, Minnesota, USA) 
• Custom made loading chambers 
• Custom cut spacers (4 and 7 mm thick) 
• Incubator (37 °C) 
• Water bath (37 °C, Fisher 15-474-35) 
• Micropipette  
• Sterile pipette tips (100-1000 µL) 
• Sterile blunt-nosed tweezers 
• Small screw driver 
 
Procedure: 
 
*Note: all steps should be performed in the laminar flow hood unless otherwise noted.  
 
1. Autoclave all tools before starting (tweezers, screw driver, custom chambers and spacers) 
2. Warm media in water bath (37 °C) for 20 minutes or until warm. 
3. Remove seeded scaffolds from the incubator (37 °C) and place in laminar flow hood 
along with autoclaved materials and warmed media. 
4. Disassemble chambers, taking care not to lose any small parts. 
5. Secure non-mineralized compartment of the scaffold to the moveable upper grip. Tighten 
screws such that they will hold the scaffold, but not so tight that they tear the scaffold 
upon movement. 
6. Carefully insert the moveable upper grip into the chamber and gently pull the scaffold 
into the chamber. Attach the mineralized compartment of the scaffold to the bottom, 
stationary grip. Tighten screws such that they will hold the scaffold, but not so tight that 
they tear the scaffold upon movement. Note that load chambers provide a 10 mm gauge 
length. 
7. Pipette warmed complete media into the chamber as it lies horizontally. Slide the glass 
chamber over the main chamber to create a water-tight seal. 
8. Carefully slide the custom made spacers to the desired strain (0, 7, 11, 15, or 20 percent 
strain) using small spacers (0.4 mm and 0.7 mm). 
9. Place chambers in the incubator for desired time. 
10. Image samples as described in A.16 
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A.16: Confocal Imaging Protocol 
Reference: (Martin et al. 2010) 
Reagents  
• Formalin solution, 10% formaldehyde in neutral buffer (Polysciences 08379-3.75)  
• Sterile phosphate-buffered saline without Ca2+  or Mg2+ (PBS)  
• AlexaFluor® 555-phallodin (Invitrogen A34055); store at -20°C  
• Hoechst 33342 stock (Invitrogen H3570) store at 4°C  
 
Supplies and equipment  
1. 6-well plates  
2. Kimwipes  
3. Tweezers  
4. Leica TCS SP2 laser scanning confocal microscope (Leica Microsystems GmbH, 
Wetzlar, Germany)  
5. ImageJ analysis software  
 
Nuclei/Actin staining procedure  
 
1. Rinse samples in PBS to remove dead/unattached cells and then place samples in 
formalin. Store at 4°C overnight, replace formalin, and store at 4°C until next step.  
2. Wash scaffolds in PBS for 1 min (3x).  
3. Incubate scaffolds in 0.1% Triton X100 in PBS for 15 min.  
4. Wash scaffolds in PBS for 1 min (3x).  
5. Dilute 25 μL of AlexaFluor® 555-phallodin dye methanolic stock solution per 1 mL 
PBS.  
6. Incubate scaffolds in solution for 30 min. Keep samples in the dark.  
7. Wash scaffolds in PBS for 1 min (3x).  
8. Dilute 1 μL of DAPI or Hoechst stock per 800 μL PBS and incubate scaffolds in solution 
for 5 min. 
9. Wash scaffolds in PBS for 1 min (3x).   
10. Store scaffolds in PBS in the dark at 4°C until imaging.  
 
Confocal imaging procedure 
 
*Note: This procedure was performed in the Screen Lab at Queen Mary University of London. 
The IGB core facility has a confocal with slightly different imaging procedures. 
 
1. Reserve time on confocal microscope using google calendar. 
2. Turn on PC 
3. Turn scanner on (on microscope tower) 
4. Turn on all fans and let them equilibrate for approximately 20 minutes. 
5. Turn Ar/ArKr laser to start, hold, release (458 nm, 476 nm, 488 nm, 496 nm, and 514 nm 
wavelength capabilities) 
6. Turn HeNe laser on (543 nm and 633 nm capabilities) 
124 
 
7. Turn on mercury bulb (note: if mercury bulb is turned off, the bulb must cool for 30 
minutes before it is turned back on). 
8. Turn UV laser on (switch is located on a black box below the computer, with an 
additional switch next to the microscope. Both must be turned on) 
9. Log into windows using QMUL id and password. 
10. Turn on microscope. 
11. After microscope has initialized, open Leica No MP on desktop, accept “Personal” and 
click start. 
12. To look through the visual binoculars, make sure the port is marked as VIS, the filters are 
not blocked (the rod is pulled out), and the magnification is 1X. The filter wheel is 
marked as 1) UV for DAPI or Hoechst 2) Red emission for TRITC or Alexa-594 3) 
Green emission for GFP, FITC, or Alexa-488 and 4) Scan for confocal. 
13. On the Leica software, load profile. 
14. Pick the objective to use (20X) 
15. Adjust image. For CG scaffolds stained with Hoechst and phalloidin Alexa-555 the offset 
was typically around 2 and the gain was approximately 500-700. For phalloidin Alexa-
555, the excitation wavelength was 543 and collected between 560-700 nm. For Hoechst, 
the UV laser collected between 370-535 nm using a filter of ND50. If the image is not 
clear enough, the filter can be reduced. 
16. When finished, turn everything off in the reverse order of what was turned on. Leave the 
fans running for approximately 20-30 minutes. 
17. Analyze images on personal computer using ImageJ software. 
  
125 
 
A.17: Visualization of Immobilized Proteins (Bulk Digestion) 
Reference: (Pence 2012) 
Reagents 
• Papain buffer (100 mL); store at 4ºC 
o 100 mL PBS 
o 1 mL 0.5 M EDTA (pH = 8.0, Sigma-Aldrich EDS); store at 4ºC 
o 79 mg cysteine-HCl (Sigma-Aldrich 00320) 
• Papain from Carica papaya (Sigma-Aldrich 76218); store at -20ºC 
 
Supplies and equipment 
• Black 96-well plates (Fisher 14-245-177) 
• Vortex (Fisher 02-215-365) 
• Water bath (60 °C, Fisher 15-460-2SQ) 
• Fluorescent spectrophotometer (Tecan F200) 
• Microcentrifuge tubes (1.5 mL) 
• Conical centrifuge tubes (15 and 50 mL) 
• Kimwipes 
• Sterile blunt-nosed tweezers 
 
Procedure 
1. Prepare papain solution by adding 2.4 mg of papain to 1 mL of papain buffer. Let 
solubilize in 60 °C water bath for ~10 minutes. Vortex thoroughly to mix. 
 
Standard Preparation 
1. Pipette 200 μL digest solution into each standard tube. 
2. Dab blank scaffolds dry on Kimwipe and place in 1.5 mL microcentrifuge tubes with 
papain solution 
3. Add 10 μL of the protein solution used for immobilization at the desired concentration 
into each standard tube. For blank scaffolds, use 10 μL of PBS. 
4. Place tubes in 60 °C waterbath for 1 hour or until scaffolds are digested. 
5. Vortex each tube thoroughly. 
6. Pipette 100 μL from each tube into a black 96-well plate. 
7. Immediately read plate on Tecan F200 fluorometer. Load protocol. For AlexaFluor 488 
streptavidin use excitation and emission. For AlexaFluor 647-Con A biotin use: 
excitation: 485 (20 nm bandwidth) and emission: 535 (25 nm bandwidth) excitation: 620 
nm (20 nm bandwidth) and the emission: 670 nm (25 nm bandwidth). 
8. Plot normalized intensity (y axis) vs. amount of protein (ConA) (x axis). KLGMN6OFPBI QRDBR@FDST = KUBM6VB W6NAOB QRDBR@FDST − KYO6RZ QRDBR@FDST 
9. Fit the curve with the best fit line. 
 
Sample Analysis 
1. Pipette 200 μL of papain solution into each labeled 1.5 mL microcentrifuge tube. 
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2. Dab blank scaffolds dry on Kimwipe and place in 1.5 mL microcentrifuge tubes with 
papain solution 
3. Place tubes in 60 °C waterbath for 1 hour or until scaffolds are digested. 
4. Vortex each tube thoroughly. 
5. Pipette 100 μL from each tube into a black 96-well plate. 
6. Immediately read plate on Tecan F200 fluorometer. Load protocol. For AlexaFluor 488 
streptavidin use excitation and emission. For AlexaFluor 647-Con A biotin use: 
excitation: 485 (20 nm bandwidth) and emission: 535 (25 nm bandwidth) excitation: 620 
nm (20 nm bandwidth) and the emission: 670 nm (25 nm bandwidth). 
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A.18: Visualization of BP Patterns 
Reference: (Martin et al. 2010) 
 
Reagents: 
• 0.2% pluronic F-127 rinse buffer 
• 1% bovine serum albumin in PBS 
• Rabbit anti-PDGF-BB antibody (AbCam, Cambridge, MA) 
• Rabbit anti-BMP-2 antibody (AbCam, Cambridge, MA) 
• Alexa Fluor 647-conjugated goat anti-rabbit IgG (Invitrogen, Carlsbad, CA) 
 
Supplies and equipment: 
• Fluorescence slide scanner (Axon Instruments-Molecular Devices, Sunnyvale, CA)  
 
Procedure: 
 
1. After patterning (see protocol A.9) membranes containing immobilized proteins (either 
PDGF-BB or BMP-2) were transferred from the 0.2% pluronic F-127 rinse buffer into a 
solution of 1% BSA in PBS for 1 hour.  
2. Each antibody (rabbit anti-PDGF-BB antibody or rabbit anti-BMP-2 antibody) was pre-
incubated with Alexa Fluor 647-conjugated goat anti-rabbit IgG in 1% BSA-PBS for at 
least 1 hour at 1µg/mL each. 
3. Membranes were placed in the relevant antibody staining solutions overnight at 4ºC. 
4. After staining, membranes were rinsed for at least 1 hour in PBS and visualized using a 
fluorescence slide scanner 
 
  
128 
 
A.19: Nuclei and Actin Orientation Analysis 
Reference: (Thévenaz et al. 2011; Steven Thorpe; FFT Analysis?) 
 
Supplies and equipment: 
• Computer 
• ImageJ analysis software  
• Ovuscule plug-in for ImageJ 
• Images to be analyzed (preferably in .tiff format) 
 
Procedure: 
1. Obtain images as in A.16 using Leica TCS SP2 laser scanning confocal microscope 
(Leica Microsystems GmbH, Wetzlar, Germany) 
 
Nuclei Orientation and Aspect Ratio Procedure 
1. Load nuclei stained image in ImageJ. 
2. Go to Image -> Adjust -> Threshold and pick a consistent threshold over which to 
analyze the images. Note that it is easier to visually check ovuscule’s yellow oval against 
a black background, but any consistent degree of thresholding is acceptable. 
3. Open Ovuscule (Plug-ins -> ovuscule). 
4. Manually drag the yellow oval around the first cell nuclei. 
5. Press “space” on the keyboard or press the play button on the toolbar. 
6. Visually check that the yellow oval has converged around the cell nuclei. If it has not, 
repeat steps 4 and 5. 
7. Press “enter” or save on the toolbar to save the data. 
8. Repeat process for every nuclei in the image 
9. Copy and paste the data output into excel or save as a text file. 
 
Actin Orientation Procedure 
1. Load each group of actin images into the work path of MATLAB and run the following 
code. *Note that all MATLAB code was provided by Stephen Thorpe. 
 
MainActinOrient.m 
% Script for running actin alignment for Laura's actin images 
 
close all; 
clear all; 
clc 
 
XLfilename = 'ResultsMain.xlsx'; %Filename for results output 
 
Resultlist = {'Filename','Fibre angle','Coalignment ratio','Angle deviation',... 
    'Analysed fibre area'}; 
l = 2; %line to start results output in excel sheet 
 
% Set number of characters to ignore at start of figure name for output 
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% name 
beginning = 0; %13; 
 
% Main Algorithm 
filenames = dir('*.tif'); %read in file names in directory 
s = numel(filenames); 
for p = 1:s 
    fname = filenames(p).name; 
    OutName = fname(beginning+1:end-9); 
    Resultlist{l,1} = OutName; %Image name for results list 
     
    IR = imread(fname); 
     
    [IRDir IRCR IRAD AnArea] = FibreOrient4(IR); %Call actin function FibreOrient4  
    Resultlist{l,2} = IRDir; % Mean fibre orientation 
    Resultlist{l,3} = IRCR; % Mean coalignment ratio for fibre orientation 
    Resultlist{l,4} = IRAD; % Mean angle deviation for fibre orientation 
    Resultlist{l,5} = AnArea; % Area analysed/Total area (less removed edges) 
 
    l = l+1; % Increment line number 
end 
xlswrite(XLfilename,Resultlist); %Output excel sheet with result list 
 
FibreOrient4.m 
%close all; 
%clear all; 
% clc 
function [IRDir, IRCR, IRAD, AnArea] = FibreOrient4(I) 
 
% Imagefile = uigetfile('*.tif','Select the .tif file for analysis'); 
% I = double(imread(Imagefile)); 
if size(I,3) == 3 
    I = I(:,:,1); %Select channel: 1 for red, 2 for green, 3 for blue 
end 
 
%Image average smoothening by (i)th times 
I2 = double(I); 
h = fspecial('average'); 
for i = 1:4 
    I2 = imfilter(I2,h); 
end 
[T1] = ThreshMode2(I2); 
[IRT] = ApplyThresh(I2,T1); 
 
IRT1 = IRT; 
% Speckle removal 
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[cluster_mat, cluster_num] = bwlabeln(IRT1); %Cluster each group of pixels 
for i=1:cluster_num 
        [row,col] = find(cluster_mat == i); 
        if length(row) < 10; %Find small clusters, i.e. speckles 
            for l=1:length(row) 
                IRT1(row(l),col(l))=0; %Make zero 
            end 
        end 
end 
 
% Dilate and erode 
se90 = strel('line', 2, 90); %Morphological structuring elements for dialtion 
se0 = strel('line', 2, 0); 
seD = strel('disk',1); %Morphological structuring element disk of radius 1 
IRT2 = imdilate(IRT1,[se90 se0]); %Each border pixel is turned into a 3x3 cross 
IRT3 = imerode(IRT2,seD); 
 
% Reduce image size 
I3 = I2.*IRT3; 
IR = imresize(I3,0.5); %Reduce image size by factor 
 
%IR = I; 
 
s = 3; %Mask size 
sigma = 3; %Area of influence of the mask 
hx = zeros(s); 
hy = zeros(s); 
for i = 1:2*s+1 
    for j = 1:2*s+1 
        m = i-s-1; 
        n = j-s-1; 
        hx(j,i) = (2*m/sigma^2)*exp(-(m^2+n^2)/sigma^2); %x directed mask 
        hy(j,i) = (2*n/sigma^2)*exp(-(m^2+n^2)/sigma^2); %y directed mask 
    end 
end 
Gx = conv2(IR,hx,'valid'); 
Gy = conv2(IR,hy,'valid'); 
G = sqrt(Gx.^2+Gy.^2); %Gradient magnitude 
IntGrad = -atan(Gy./Gx); %Intensity grad 
PhiLocalrad = IntGrad+pi/2; %Local direction of orientation 
PhiLocal = PhiLocalrad*180/pi; %Convert from radians to degrees 
 
IR1 = IR(s+1:(length(IR)-s),s+1:(length(IR)-s)); 
IThresh = 0.4*mean(mean(IR1)); %Threshold for whether region is analysed 
m = 25; %Subimage side length 
numw = (floor(length(G)/m))^2; %Number of subregions 
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A = zeros(180,numw); %Accumulator bins for each subregion 
CR = zeros(180,numw); 
Pix = zeros(180,numw); 
AD = zeros(numw); 
w = 1; %Subregion number 
nan = isnan(PhiLocal); 
for p = 1:floor(length(G)/m) %Loop through each sub region 
    pstart = (p-1)*m+1; 
    pend = p*m; 
    for q = 1:fix(length(G)/m) 
        qstart = (q-1)*m+1; 
        qend = q*m; 
        M = IR1(pstart:pend,qstart:qend); 
        M = M(:); 
        Mnan = nan(pstart:pend,qstart:qend); 
        Mnan = Mnan(:); 
        PhiM = PhiLocal(pstart:pend,qstart:qend); 
        PhiM = PhiM(:); 
        PhiM(Mnan==1) = []; 
        GM = G(pstart:pend,qstart:qend); 
        GM = GM(:); 
        GM(Mnan==1) = []; 
        if mean(M) > IThresh 
            for theta = 1:180 % For each angle bin from 0 to 180 degrees 
                AnglWt = exp(2*cosd(2*(theta-PhiM)))/exp(2); % Angle weighting 
                Aw = GM.*AnglWt; % Angle bin value weighted to gradient magnitude 
                A(theta,w) = sum(Aw); %Angle weighting 
                CR(theta,w) = sum(AnglWt)/length(AnglWt); %Coalignment ratio 
            end 
            AD(w) = std(PhiM); %Angle deviation 
            Pix(w) = length(PhiM); %Number non-thresholded pixels 
            w = w+1; 
        else 
            IR1(pstart:pend,qstart:qend) = 255; 
        end 
    end 
end 
A = A(:,1:w-1); %Trim matrices to remove space from below threshold regions 
CR = CR(:,1:w-1); 
Pix = Pix(1:w-1); 
AD = AD(1:w-1); 
% Predominant orientation of each reion given by Dirw90 from 0 to 180 
[C Dirw90] = max(A);  
Dirw0 = zeros(numel(Dirw90,1)); % Convert angles to -90 to +90 
for i = 1:numel(Dirw90) 
    if Dirw90(i) > 90 
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        Dirw0(i) = abs(Dirw90(i)-180); 
    else 
        Dirw0(i) = Dirw90(i); 
    end 
end 
bins = 2.5:5:87.5; % Bins of 5 degrees 
H = hist(Dirw0,bins); % Histogram of number of regions in each angle bin 
[C IndDir] = max(H); % Cell's fibre orientation is orientation of max bin 
IRDir = bins(IndDir); % Output fibre orientation 
% Mean of coalignment ratios for each driection in regions principle 
% direction 
IRCR = mean(CR(Dirw90)); 
IRAD = mean(AD); % Mean or region angle deviations 
% Fraction of total pixels analysed. i.e. above threshold and in region 
% above threshold. 
AnArea = sum(Pix)/numel(IR1); 
 
ApplyThresh.m 
function [IThresh] = ApplyThresh(I,T) 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%This function receive the image to be thresholded and the threshold value. 
%This function then produce a thresholded image. 
%I: image to be thresholded 
%T: threshold value 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
 
clear row column int S sizerow sizecolumn R C 
 
[row,column,int] = find(I>T);   
S = length(row); 
[sizerow,sizecolumn] = size(I); 
IThresh = zeros(sizerow,sizecolumn); 
for i = 1:S 
    R = row(i,1); 
    C = column(i,1); 
    IThresh(R,C) = 1;           
end 
 
ThreshMode2.m 
function [Thresh] = ThreshMode2(I) 
 
% This function receives an image and uses a unimodal threshold selection 
% algorithm adapted from the k-means clustering algorithm. This has been 
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% proven to converge at a local minimum, such that a different initial 
% threshold may give a different final result 
 
T1 = uint8(mean(mean(I))); %Get initial threshold value 
c = false; %for convergence 
i = 0; 
while c == false 
    G1 = I(I<=T1); %All pixels less than threshold 
    G2 = I(I>T1); %All pixels above threshold 
    m1 = mean(G1); %Average pixel value below threshold 
    m2 = mean(G2); %Average pixel value above threshold 
    T2 = uint8((m1+m2)/2); %New threshold 
    if T1 == T2 %when old and new thresholds equal, convergence reached 
        Thresh = T2; 
        c = true; 
    else 
        T1 = T2; 
    end 
    i = i + 1; %To ensure it doesn't run forever if no valley 
    if i > 10000 
        Thresh = 0; 
        return 
    end 
end 
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